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ABSTRACT 
 This dissertation describes attempts to develop new methodology in the Dougherty lab, ultimately 
focused on controlling biological systems. It is split between two fields of study. The first is exploring 
new ways to utilize noncanonical amino acids. The second is development of new photochemistry based 
on NIR chromophores.  
 The first chapter describes attempts to use noncanonical amino acids to study nuclear receptors in 
Xenopus laevis oocytes. Nuclear receptors are vital to cell regulation, however, due to a lack of structural 
information, are still poorly understood. Structure-function studies, similar to those performed in ligand-
gated ion channels in the Dougherty lab, would provide significant insight into the function of these 
proteins. Methodology was developed for analyzing the activity of a specific nuclear receptor, the retinoic 
acid receptor, based on a quantitative reverse transcriptase polymerase chain reaction.  
The second chapter discusses attempts to introduce noncanonical amino acids into mammalian cells 
using the chemical acylation methodology. Successful incorporation of noncanonicals would allow ion 
channels to be evaluated in their native environment, expanding on the work previously done by the 
Dougherty lab. A number of different transfection methods were explored, as well as ways to increase 
tRNA stability post transfection.  
The third chapter bridges the gap between chemical biology and photochemistry, and focuses on the 
exploration of singlet oxygen-sensitized delayed fluorescence (SOSDF) as a potential tool for visualizing 
biological systems. An experimental set-up was devised for evaluating the weak fluorescence produced 
by SOSDF and a number of SOSDF systems were characterized.  The effect of sensitizer and emitter 
concentrations on SOSDF were evaluated, both as a function of fluorescence intensity and lifetime. 
Progress towards the practical application of SOSDF is described. 
The fourth chapter focuses on the development of phenothiazine derivatives for use as NIR singlet 
oxygen generators and photoremovable protecting groups. A range of derivatives were characterized, and 
their applications explored. An updated series of singlet oxygen-sensitize protecting groups based on the 
 ix 
anthracene backbone are also described, as is their attempted introduction into a phenothiazine 
derivative.  
The fifth chapter describes the development of long wavelength triplet sensitizers based on 
heptamethine dyes. These sensitizers provide access to the triplet state and consequently singlet oxygen 
at NIR wavelengths, making them a valuable addition to the limited NIR photochemistry tool set. The 
synthesis and analysis of these dyes is discussed, as is their application for the generation of singlet oxygen.   
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Chapter 1: Exploration of the Use of Noncanonical Amino Acids to Study Nuclear 
Receptors in the Xenopus laevis oocyte Model System 
 
1.1 Abstract 
The Xenopus laevis model system has been used extensively in the Dougherty lab to study ion channels 
containing noncanonical amino acids. Introduced via a chemical acylation methodology, these 
noncanonical amino acids have provided a mechanistic understanding of ion channel function, generating 
insights that transcend the static world of crystallography. Despite the utility of this technique, it has 
found little use beyond ion channels, as the method requires a stoichiometric amount of tRNA for protein 
production. Practically, this means that only systems with significant signal amplification – such as ion 
channels – can be observed. In an attempt to expand this technique to a new set of proteins, another 
system with significant signal amplification was explored: nuclear receptors. This class of proteins is 
responsible for transcriptional regulation, meaning that mRNA levels within a cell can be correlated with 
the function of a nuclear receptor. Although transcriptional activation itself does not provide enough 
signal amplification to explore the mechanistic subtleties introduced by noncanonical amino acid 
mutagenesis, the mRNA can be amplified and quantified using a reverse transcriptase quantitative 
polymerase chain reaction (RT-qPCR).  Described herein are initial attempts at using Xenopus laevis 
oocytes, noncanonical amino acids, and RT-qPCR to explore transcriptional activation in the nuclear 
receptor RARα, as well as subsequent attempts made in HEK-293T cells.  
1.2 Introduction 
1.2.1 Noncanonical Amino Acids 
Life has achieved incredible biochemical diversity based on a simple suite of 20 amino acids. Although 
these building blocks have proven a sufficient basis for the complexity of the world around us, they are 
still lacking in the eyes of the modern chemist. The discovery of selenocysteine in the early 1970s1 
suggested that the proteinogenic code was not as strict as originally thought, and by 1989 the first 
noncanonical amino acid had been incorporated into a protein in vitro.2 Schultz contributed heavily to this 
field, rapidly developing an array of noncanonical amino acids. By 1995, the first unnatural amino acid 
had been incorporated into a protein expressed in a vertebrate cell via a collaboration between the Schultz, 
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Lester, and Dougherty labs.3 Since this time, three methods for the incorporation of unnatural amino 
acids have become predominant, each with their own strengths and weaknesses.  
 Noncanonical amino acid 
incorporation can be broken down into 
two different types: residue-specific and 
site-specific. In residue-specific 
noncanonical amino acid incorporation, 
a residue is exchanged for a noncanonical 
counterpart throughout the cell; for 
instance, a methionine could be 
exchanged for an azidohomoalanine 
(Figure 1).4,5 This does not mean that each methionine in a cell would be an azidohomoalanine, but rather 
each methionine could be an azidohomoalanine. In the most basic systems, this is done by taking an 
auxotrophic organism and depriving it of an essential amino acid. As protein synthesis continues, the 
pool of tRNA acylated with the essential amino acid is depleted, leaving unacylated tRNA and halting 
protein synthesis.4 At this point, a noncanonical amino acid is introduced, which the cell uses to charge 
unacylated tRNA using the standard cellular machinery.4 Without additional mutagenesis, only 
noncanonical amino acids that closely resemble a canonical amino acid can be used. Despite this 
limitation, a variety of functional amino acids have been introduced, enabling a wide array of proteomic 
studies and protein-based materials.6 This technique has also found use in crystallography labs, where 
cysteine is exchanged for selenocysteine, enabling easier crystallographic analysis.7 
In site-specific noncanonical amino acid incorporation, a specific residue in a specific protein is 
substituted for a noncanonical residue, one which is not limited by homology (Figure 1).5,8 To achieve 
this, a tRNA is developed that recognizes a codon that is orthogonal to the host organism’s translation 
system. Typically, these tRNA are evolved from those found in organisms that encode greater than 20 
amino acids. They often recognize stop codons such as TAG, and, to ensure orthogonality, are evolved 
Figure 1: Comparison of residue specific and site specific 
incorporation. Adapted from Yun et al.5 
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to be incompatible with tRNA synthetases endogenous to the host organism.8 These tRNAs can be 
charged in two different manners. The first, known as enzymatic acylation, relies on the development of 
tRNA synthetases capable of enzymatically acylating tRNA with novel amino acid substrates.8 These 
synthetases must be completely orthogonal to the organism they are introduced into and require 
significant effort to evolve. Once generated, however, they are extremely robust and capable of producing 
high protein yields. This methodology leads to efficient site-specific incorporation of noncanonical amino 
acids, but is ultimately somewhat restricted in substrate scope due to limitations on synthetase 
orthogonality and enzymatic evolution. Enzymatic acylation has found widespread use, from basic 
biochemistry to protein-drug conjugates.9   
 Chemical acylation exists as a foil to enzymatic acylation; it gives nearly limitless flexibility in terms of 
the amino acid incorporated, but requires a stoichiometric amount of tRNA for protein production, 
resulting in low yields.10 In chemical acylation, the amino acid of interest is attached through a set of 
synthetic steps that culminate in the ligation of a truncated tRNA to an oligonucleotide containing an 
amino acid of interest.10 This tRNA is then introduced into a host system, where it can interact with an 
orthogonal codon in the same way an enzymatically labeled tRNA would. Despite the wide range of 
noncanonical amino acids that can be accessed with the methodology, chemical acylation has found much 
more limited use than the aforementioned methods, primarily being used in vitro and in the study of ion 
channels in Xenopus laevis oocytes.10 
Starting with the incorporation of phenylalanine and tyrosine derivatives in the muscle type nicotinic 
acetylcholine receptor in 1995, the Dougherty lab has used the Xenopus laevis model system to perform 
extensive chemical scale analyses on ligand-gated ion channels (Figure 2), a class of proteins that lend 
themselves to the chemical acylation methodology due to the signal amplification they provide. A single 
ion channel controls the flow of millions of ions, allowing even small amounts of protein to be observed 
through electrophysiology.10 In two decades of electrophysiology, a number of binding interactions have 
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been probed and a vast array of noncanonical 
amino acids have been incorporated. 
Especially unique are alcohol analogs of 
amino acids, residues that cannot be done 
with any other methodology (Figure 3).10 
Ideally, it would be possible to expand the 
strengths of the chemical acylation 
methodology to a different set of proteins or 
a different model system all together. One 
particularly interesting set of proteins are 
transcription factors.  
Transcription factors, are proteins that 
regulates a cell’s response to stimuli by 
controlling the process of RNA generation. 
By producing multiple transcripts of RNA, a 
single transcription factor is capable of 
producing a substantial amplification event. 
Although significant, it is unlikely that this 
event alone would be capable of producing 
sufficient signal amplification for evaluation. 
However, RNA production can be paired 
with another amplification event, reverse 
transcriptase quantitative polymerase chain 
reaction (RT-qPCR). In RT-qPCR, primers 
are used to transcribe RNA to DNA using a 
reverse transcriptase. At this point, a set of 
Figure 2: Methodology for chemical scale analysis of 
ligand-gated ion channels. Adapted from Dougherty et 
al.10 
Figure 3: A selection of noncanonical amino acids 
incorporated by the chemical acylation method. 
Adapted from Dougherty et al.10 
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traditional PCR cycles is carried out, and 
a dye that intercalates DNA is 
incorporated to give a quantitative 
readout with regards to the amount of 
DNA that is produced (Figure 4).11,12 By 
evaluating the number of cycles 
required to attain a certain fluorescence threshold, it is possible to determine the amount of RNA initially 
present. By combining these two types of amplification, it may be possible to observe changes in 
transcription factor activity mediated by chemically acylated tRNA.  
 Transcription factors are regulated by a number of processes, from ligand binding to post-
translational modification. As our lab’s previous research has focused heavily on binding interactions, we 
chose to focus initial studies on ligand-regulated transcription factors known as nuclear receptors.   
1.2.2 Nuclear Receptors 
 Nuclear receptors are a specific subset of ligand gated transcription factors.  With 48 unique nuclear 
receptors identified in humans, they play a prominent role in gene regulation.13 They are responsible for 
the detection of sterols, fatty acids, and retinoids, and have been implicated in diverse physiological 
processes, from metabolism to immunity.13,14 The family of nuclear receptors is defined by its conserved 
evolutionary template.14 Each nuclear receptor has two domains – a ligand-binding domain and DNA-
binding domain – linked by a flexible hinge region, as well as a functionally important N-terminal 
region.13,14 Nuclear receptors are generally grouped into three classes: those that act as monomers, those 
that act as homodimers, and those that act as heterodimers with the retinoid X receptors.13 A number of 
examples exist for all three classes, and some nuclear receptors have been shown to stimulate 
transcription in more than one manner.13,14 
 Each nuclear receptor binds to a unique six base DNA consensus sequence, and dimer pairs require 
specific distances between these individual consensus sequences.13 The two consensus sequences along 
with the bases in between constitute a response element for a given heterodimer.13 This rigid spatial 
Figure 4: qPCR fluorescence readout. Adapted from Sigma 
Aldrich.12 
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requirement suggests the otherwise flexible hinge region plays an integral role in controlling the relative 
orientation of the ligand-binding domain and the DNA-binding domain upon formation of a dimer.13 In 
addition to the hinge region, it is thought that interactions with co-activators, of which there are over 150 
for nuclear receptors, play a large role in controlling the relative positioning of the two DNA-binding 
domains.13 These co-activators are thought to bind at one of two distinct sites: the activation function 1 
surface (AF1) in the N-terminal region and the activation function 2 surface (AF2) in the ligand-binding 
domain.13 
Given the complexity of transcriptional regulation in the nuclear receptor family, analysis of nuclear 
receptors – particularly the relationship between structure and function – has proven far from trivial.14,15 
Although the crystallization of nuclear receptors, particularly dimeric complexes, has provided some 
functional insight, structure based analyses are complicated by the high level of disorder intrinsic to many 
transcription factors.15–18 This disorder is often associated with regions involved in transcriptional 
activation and complex formation, and thus poor crystallographic resolution is obtained in functionally 
interesting regions. Precise structure-function studies, which could be performed using noncanonical 
amino acids, would drastically improve current knowledge of nuclear receptor function. Of particular 
interest among these receptors are the retinoic acid receptors. 
1.2.3 Retinoic Acid Receptors 
In humans, there are three unique retinoic acid receptors (RARα, RARβ, and RARγ) and three unique 
retinoid X receptors (RXRα, RXRβ, and RXRγ).19 Each of these receptors is encoded by a distinct gene, 
and a number of RAR/RXR dimers have been described.19 These dimers regulate gene expression by 
recruiting transcriptional complexes to retinoic acid response elements (RAREs) in DNA, and have been 
implicated in cell cycle regulation.19 The RARα/RXRα heterodimer is of particular interest due to the role 
RARα plays in promyelocytic leukemia, where a fusion protein consisting of domains from the 
promyelocytic leukemia protein and RARα has been shown to activate oncogenes.19 This dimer has been 
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well characterized biochemically, 
however, only limited structural data 
exists.20,21  As is common for 
transcription factors, significant portions 
of available structures – such as the N-
terminal domain and hinge region – are 
not resolved.  
 It is believed that, in the absence of 
ligand, the RARα/RXRα dimer interacts 
with a corepressor complex that 
suppresses transcription at RAREs.19 
The binding of all-trans retinoic acid 
(ATRA) alters the activity of the 
heterodimer, increasing its affinity for 
coactivator proteins while decreasing its 
affinity for the corepressor complex.19 This process of receptor activation involves a number of events 
(Figure 5). In addition to binding RARα, ATRA activates the p38MAPK signaling pathway.22 This allows 
the kinase MSK1 to phosphorylate RARα at serine 369, a residue in the ligand binding domain adjacent 
to AF2.22 Following this initial phosphorylation, a secondary phosphorylation – mediated by cyclin H 
and the kinase CDK7 – can occur at serine 77 (S77), a residue in the RARα N-terminal domain near 
AF1.23 This second phosphorylation 
results in RARα activation, and leads 
to increased nuclear localization of 
the transcription factor.23,24 The 
importance of phosphorylation at 
this site has been corroborated 
Figure 6: Differential DNA binding for WT and S77A 
RARα/RXRα heterodimers. Adapted from Rochette-Egly et 
al.23 
Figure 5: Proposed Activation Pathway for RARα/RXRα 
Heterodimer. Adapted from Rochette-Egly et al.22 
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through an alanine mutation (S77A), which greatly reduces the ability of RARα to bind DNA at RAREs 
(Figure 6).23 How phosphorylation at S77 mediates binding is still unclear. One possibility is through 
interaction with the proceeding residue, proline 78 (p78), as a phosphorylated serine residue adjacent to 
a proline residue constitutes the minimum motif required for interaction with the phospho-directed prolyl 
isomerase Pin1.25 Although a relationship between Pin1 
mediated isomerization and transcriptional activation 
has yet to be established, isomerization at P78 is known 
to occur, and is well documented in another context.26 It 
has previously been shown that degradation of RARα is 
dependent on both interaction with Pin1 and 
phosphorylation at S77, implying that isomerization 
occurs at P78 and is integral to degradation of the 
protein (Figure 7).26  
1.2.4 Prolyl Isomerization and Pin1 
  Of the canonical amino acids, proline is the only residue to adopt a cis conformation to an appreciable 
extent (about five percent).27 Although the cis conformation is heavily disfavored and spontaneous 
isomerization between the two forms is slow, prolyl isomerases make isomerization events relevant on a 
biological time scale.27 In fact, prolyl isomerization has been shown to play a regulatory role in a number 
of biological systems.27 Four structurally distinct classes of prolyl isomerases have been identified, three 
of which have similar substrate specificity.27 The fourth, which includes Pin1 and Pin1 like enzymes, is 
unique in that members of the class are phosphorylation dependent: they catalyze prolyl isomerization 
for prolines adjacent to phosphorylated serine and threonine residues.19 The other three classes are 
incapable of catalyzing such isomerizations.27 Pin1 and similar enzymes are particularly important in 
regulation because of this orthogonal substrate scope.27  
Of the Pin1 like enzymes, Pin1 is the most studied. Pin1 catalyzes both trans-cis and cis-trans 
isomerization, and therefore does not bias the conformational equilibrium; if the intrinsic cis bias is only 
Figure 7: Regulation of RARα 
concentration by phosphorylation at 
serine 77. Adapted from Klimkait et al.26  
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five percent, this will not be altered by the isomerase.25 However, in the event that one isoform is depleted 
by biological activity, this rapid isomerization allows it to be replaced on a biologically relevant time 
scale.25 Given that isomerization is often linked to subsequent events that preclude further isomerization 
– such as complex formation –  this allows substrate to be funneled towards an active conformation.25 It 
is worth noting that catalysis via Pin1 is significant; uncatalyzed isomerization of phosphorylated 
serine/threonine-proline bonds is significantly slower than other cis-trans isomerizations, essentially 
locking the backbone in place.27 
 Despite the prevalence of Pin1 mediated processes in biology, few assays exist for detecting Pin1 
activity. Although in certain systems – such as Pin1 mediated degradation of RARα – there is a direct 
functional output, often times this is not the case.26 For instance, in RARα mediated gene transcription, 
the effects of isomerization at proline 78 cannot easily be differentiated from the effects of 
phosphorylation at serine 77. In systems that lack a direct functional output, mutagenesis can be used to 
probe the importance of Pin1 isomerization, albeit a significant caveat limits the utility of the technique. 
Although prolyl mutation implies a lack of functional importance when protein activity is unaffected by 
mutation, the converse is not true. Proline can play an integral structural role independent of 
isomerization, therefore a lack of protein activity following prolyl mutation can not necessarily be 
attributed to a functionally important isomerization. This ambiguity greatly limits the utility of traditional 
mutagenesis, however, noncanonical amino acid mutagenesis can be used to differentiate between these 
scenarios.  
  Noncanonical amino acid mutagenesis offers a compelling means by which to explore Pin1 mediated 
isomerization, as noncanonical residues could be used to uncouple the roles of phosphorylation and 
isomerization at a given site. By incorporating proline analogs with a diverse range of cis preferences in a 
phosphorylation incompetent mutant, it would be possible to directly observe the effect of altered cis-
trans biases on protein activity, and thus infer the importance of prolyl isomerization. In the case of the 
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RARα/RXRα heterodimer, if cis-biased proline analogs could rescue transcriptional activity in a 
phosphorylation incompetent mutant (S77A), it would suggest that isomerization at P78 is crucial for 
activation.  
 Selection of a library of amino acids to probe the role of a proline requires significant thought. Of the 
20 canonical amino acids, proline is the only residue with a secondary backbone amine. This additional 
nitrogen-carbon bond prevents hydrogen bond formation at the backbone amide, and thus has significant 
implications for secondary structure.28 Additionally, the cyclic nature of proline introduces a number of 
steric constraints, which manifest as a significant cis-bias (about 5%).29 Alpha hydroxyl acids, N-methyl 
alanine, and a number of proline analogs have all previously been used to explore the structural role of 
proline.28 Among these, the proline analogs are of particular interest in cases where a cis-trans isomerization 
is predicted. These analogs exhibit a range of conformational preferences, as predicted by model peptides, 
and therefore can be used to probe isomerization (Figure 8).30 For example, in the 5HT-3 receptor – a 
ligand gated ion channel whose natural agonist is serotonin – receptor activation scales as a function of 
Figure 8: Various Proline Analogs and their Cis-Trans Preferences. Adapted from 
Lummis et al.30 
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conformational preference at a specific proline 
(Figure 9), suggesting isomerization played a key 
role in channel activation.30 Given the precedent 
set by this analysis, a similar set of residues was 
selected for studying the role of cis-trans 
isomerization in proline 78 of RARα. In this work, 
we discuss the development of an assay for 
analyzing nuclear receptors in Xenopus laevis 
oocytes using unnatural amino acids, with a focus on mutating serine 77 and proline 78.  
1.3 Results and Discussion 
1.3.1 Selection of an Appropriate Model System  
To probe the nature of S77 and P78 in RARα using noncanonical amino acids, a new assay had to be 
developed to evaluate transcription in Xenopus laevis oocytes. Towards this end, former lab member Tim 
Miles obtained plasmids containing RARα and RXRα, as well as a previously described reporter plasmid 
containing a retinoic acid response element linked to a luciferase gene (RARE-Luc). This reporter plasmid 
was chosen for a number of reasons. First, the plasmid was designed with three retinoic acid response 
elements, ensuring selective expression only in the presence of active RARα/RXRα heterodimer (Figure 
10). Second, the plasmid had previously been used in Xenopus laevis oocytes for a luciferase luminescence 
assay, making it a good starting point for experiments utilizing a qPCR readout.31 Finally, in the event of 
issues with the RT-qPCR readout, the plasmid offered the possibility of a chemiluminescence read out. 
Tim also designed luciferase specific primers for 
the qPCR readout and selected Xenopus laevis 
reference genes for the assay: glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) and 
ornithine decarboxylase (ODC). 32,33  
Figure 9: EC50 as a function of conformational 
preference.  Adapted from Lummis et al.30 
RAR
E 
SV40 Luciferas
e 
Figure 10: Cartoon representation of RARE-Luc. 
An SV40 promoter serves as the base promoter, with 
RAREs (one forward and two reverse, as denoted by 
the arrows) regulating the expression of luciferase. 
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 To assay luciferase transcript production using native RARα, the following experiment was performed 
by Tim Miles.34 Oocytes were injected internuclearly with the RARE-Luc reporter plasmid, given a 24-
hour recovery period, and then injected cytoplasmically with RARα/RXRα mRNA. Following the second 
injection, cells were given another 24-hour recovery period to produce transcription factor, at which point 
they were incubated with or without all-trans retinoic acid (a transcriptional activator) overnight (Figure 
11). Cells were then lysed and the RNA isolated for use in RT-qPCR experiments. The efficiency of 
transcript generation was evaluated by determining the number of cycles required to reach a specific 
fluorescence threshold (Cq). To account for differences in RNA production and isolation, this value was 
normalized against a reference gene to produce the value ΔCq (where ΔCq ≡ Cq(Luciferase) – 
Cq(Reference Gene)).32 Using this methodology, the results obtained in previous luciferase assays could 
not be reproduced. Signal was unaffected by incubation with all-trans retinoic acid (ATRA), as each set 
of oocytes had a similar fluorescence threshold when normalized against the reference gene. To probe 
the cause of the constant luciferase signal, an analogous experiment was run, but receptor mRNA 
(RARα/RXRα) was not injected. A similar result was obtained, suggesting that either endogenous RARα 
Figure 11: Experimental workflow in Xenopus oocytes.  
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activity was responsible for the observed signal or that 
isolated RNA was contaminated with plasmid DNA. To 
differentiate between these two possibilities, qPCR was 
performed on isolated RNA prior to reverse transcription. 
Since single stranded RNA would not be amplified, signal 
would only be observed if significant amounts of 
contaminating DNA were present. Although the reference 
gene (GAPDH) was not amplified in this control, 
luciferase was, demonstrating that background 
contamination of DNA was a significant issue. As a work 
around, Tim attempted to introduce native luciferase introns back into the luciferase gene (Figure 12). 
Ultimately he was able to introduce an intron (intron-3) back into the gene RARE-Luc construct, but was 
subsequently unable to produce an RT-qPCR signal. 
 Taking over from this point, I decided to reevaluate the RARα and RXRα constructs to ensure that 
the lack of signal was a result of the luciferase gene and not some other component of the assay. RARα 
expression was initially analyzed by western blot using 
a His-6 tag that was previously incorporated into the 
construct. No expression was observed, suggesting that 
RARα expression was at least as much of an issue as 
the RARE-Luc construct. To determine the source of 
expression issues, the RARα DNA and RNA were 
analyzed by gel electrophoresis. Observing no issue 
with the quality of either, the construct was sequenced 
again, and a mutation was found (P403Q). Restoring 
the mutant to wild type led to clean expression of the 
protein in oocytes (Figure 13).   
Figure 12: Intron containing gene and 
associated qPCR primers. The red 
primers will selectively bind to processed 
RNA. 
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Figure 13: RARα expression blot. Lane A 
contains naïve oocytes (a negative control), 
lane B contains GLIC-expressing oocytes (a 
positive control) and lane C contains RARα 
expressing oocytes, which contain a mass 
which matches RARαs MW. 
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 At this point, complete sequencing was performed for the RXRα and intron-3 RARE-Luc constructs 
to ensure there were no other issues with the plasmids obtained from Tim. Although the RXRα construct 
contained no mutations, the intron-3 RARE-Luc construct had multiple intron-3 insertions, rendering it 
useless. While new RARE-Luc intron constructs were generated using newly designed primers, the 
original assay was reevaluated using functional RARα.  
The first experiments were designed to reproduce previous observations. This time, transcriptional 
activation was observed, although not to the extent previously reported using a luciferase assay (Figure 
14).31 After normalization to either of two reference genes, a ΔΔCq of approximately 3.5 cycles was 
observed, a value which can be used to estimate a 10-fold shift in transcription (since each cycle leads to 
a doubling in the amount of DNA). Despite the success of this experiment, such a small cycle difference 
posed a significant issue for subsequent experiments. Since noncanonical RARα mutants are expected to 
express at significantly lower levels than wild-type RARα, the observed cycle difference would be 
expected to be even smaller for RARα mutants, essentially at the level of noise. To complicate matters 
further, the results obtained were inconsistent. Even when oocytes from the same batch of cells were 
compared, the ΔCq values for the exact same experimental setup often varied by a couple of cycles. 
Comparisons between batches of oocytes were worse; ΔCq values ranging from 2 to 7 were obtained. 
Figure 14: RARα expression and transcriptional activation in the presence of 
ATRA. RT-qPCR results demonstrating successful RARα expression and transcriptional 
activation in the presence of ATRA. Each condition was run in triplicate to obtain a more 
accurate ΔCq. 
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Whether or not this was a characteristic inherent to the oocyte model system or the result of an 
unoptimized protocol was unclear. To differentiate between the two, a number of steps were taken to 
optimize the entire assay.  
1.3.2 Assay Development 
To frame discussions regarding optimization of the RT-qPCR assay, the protocol as it was originally 
performed will be described in greater depth.34 To begin each experiment, the reporter plasmid was 
injected internuclearly, at which point the oocyte was given 24 hours to rest. RARα and RXRα mRNA 
was then injected cytoplasmically, and the oocyte given another 24 hours to produce the nuclear 
receptors. After this second 24-hour period, oocytes were incubated overnight in a blacked-out container, 
either in media containing ATRA or media containing the ATRA vehicle, DMSO. Following this 
incubation, the cells were lysed and the RNA isolated using a QIAGEN RNEasy kit. On column DNASE 
I digestion was performed to increase the purity of the isolated RNA.  Upon elution of the sample, the 
quantity and quality of isolated RNA was analyzed by UV-Vis. The concentration of the sample as well 
as the ratio of the 260 nm absorbance to the 280 nm absorbance – a rough approximation of RNA purity 
known as the A260/280 – were then obtained.35 If the concentration or A260/280 value was anomalously 
low, the sample was not subjected to further analysis.35 Following UV-Vis characterization, isolated RNA 
was added to a solution containing a polythymine (poly-T) primer – which selectively reverse transcribes 
mRNA – and this solution was melted to ensure denaturation of any secondary structure that might 
interfere with polymerization.34 Polymerization was then carried out, and DNA isolated from the reaction 
used to seed triplicate RT-qPCR reactions for each of the three genes evaluated (luciferase and the two 
reference genes). To facilitate later comparison to the intron-3 RARE-Luc plasmid, intron-3 spanning 
primers were used to evaluate luciferase expression. 
Discussion of the parameters evaluated will be broken into three categories: injection conditions, 
purification conditions, and RT-qPCR parameters. Before this discussion, however, two aspects of the 
optimization experiments should be noted. First, the two reference genes – GAPDH and ODC – 
repeatedly gave analogous results while exploring the reproducibility of the system, therefore, GAPDH 
  
16 
was used exclusively for most of the optimization experiments to increase throughput. Second, creation 
of a genuine intron-3 RARE-Luc reporter plasmid proved difficult, thus most optimization experiments 
were run using the standard RARE-Luc reporter plasmid, before a genuine intron-3 reporter plasmid was 
generated.  
Injection conditions were screened first, and since any increase in experimental throughput would 
allow for increased efficiency in screening other conditions, the requirement for two 24-hour rest periods 
was the first aspect of the assay to be evaluated. This was done by comparing oocytes injected on a single 
day to oocytes that were injected over two days. Results were similar between the two populations, 
suggesting that a single injection period could be used. Taking advantage of this higher throughput, a 
number of injection and incubation conditions were screened. Although altering the amount of injected 
reporter plasmid affected the amount of background observed – with high levels of reporter plasmid 
drowning out RARα mediated signal – no other parameter significantly affected ΔΔCq values or the 
consistency of the results.  
 Given that different injection conditions seemed to have a negligible effect on the final results, RNA 
purification conditions were next screened (Table 1). The purpose of these screens was twofold. In a 
general sense, these screens were used to evaluate the ability of the A260/280 value to predict the quality 
of the qPCR outcome. The A260/280 value is often used as a rough measurement of nucleotide purity 
– with a DNA enriched sample giving a value near 1.8 and an RNA enriched sample giving a value near 
2.0 – and therefore was used by a former group member as a way to predict and comment on the quality 
of the qPCR results.35 However, given that a number of factors, such as pH and chemical contamination, 
can have significant effects on the A260/280 value, the degree to which such analysis was appropriate 
was unclear.35 After screening a number of conditions, it became apparent that the A260/280 value was 
at best a binary assay. Although values below 1.90 gave poor qPCR results, values above could not 
effectively be distinguished in terms of clustering and absolute cycle number, suggesting that assigning 
significant stock in the assay was inappropriate. Beyond evaluation of the A260/280 value, conditions 
were screened in an attempt to reduce DNA contamination. Although some conditions, such as running 
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two column purifications on the same sample, resulted in slightly improved DNA degradation, no 
method resulted in better ΔΔCq values, suggesting the additional resources and effort required by such 
purifications were unwarranted.   
 After exploring purification conditions, a number of aspects of the RT and qPCR steps were 
optimized. This was facilitated by the fact that the same RNA sample could be used to seed multiple RT-
qPCR experiments, simplifying comparisons between conditions. Among the different aspects explored, 
two sets of experiments are worth mentioning in particular. In the first set of experiments, RT reactions 
were seeded with consistent amounts of DNA rather than consistent volumes. From these experiments, 
it was determined that consistently seeding RT reactions with 1 μg of isolated RNA – rather can a 
consistent volume of inconsistent concentration as had previously been done – resulted in greater 
precision among the triplicates and enhanced reproducibility. This practice was adapted going forward. 
In the second set of experiments, different sets of RT primers were explored. Although poly-T primers 
are commonly used for studying mRNA – as mRNA is the only polyadenylated RNA and thus is 
selectively amplified by poly-T primer – they are not infallible, and thus two alternatives were evaluated: 
random hexamer primers and a gene specific primer. The former, which consists of random hexamers 
that produce nonspecific reverse transcription, is used to amplify RNA when the target is not well 
characterized.36 This set of primers produced poor precision and reproducibility, suggesting its use was 
Table 1: Screened purification conditions. An in solution digestion was always followed by a column 
purification to clean-up the sample.  
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inappropriate. The latter, which was designed to produce transcription of only luciferase gene products, 
produced a more complicated result. Although it amplified the luciferase signal as expected, it also 
amplified the GAPDH reference gene. To determine the cause of this unexpected signal, two additional 
RT experiments were run: one without the luciferase primer and one without the reverse transcriptase 
(Figure 15). Although the luciferase signal differed negligibly in these experiments, the difference in 
GAPDH signal was substantial. The lack of a primer seemed to have no effect on GAPDH reverse 
transcription, whereas the lack of a reverse transcriptase produced no signal (as expected). Although a 
surprising result, it was not unprecedented – primer-independent reverse transcription has previously 
been reported.37 A similar phenomenon was observed when the ODC reference gene was evaluated in 
the same manner. These experiments suggested that other primers offered no specific advantage, and 
thus the poly-T primer was used exclusively going forward. As an aside, in analyzing the luciferase 
controls, the value of a no RT control became apparent. Given that DNA would still be detected in a 
qPCR experiment independent of whether reverse transcription was performed, a no RT control 
provided a way to determine the amount of background signal due to DNA contamination. This control 
was run for all subsequent experiments. 
 Throughout this series of optimization experiments, it became increasingly apparent that 
inconsistencies observed were inherent to the model system. As a final attempt to work around this 
Figure 15: Luciferase specific RT-qPCR.  
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limitation, a newly generated intron-3 RARE-Luc gene was evaluated (Figure 16). No signal was 
observed, suggesting that transcription of the gene did not occur or that the intron was not processed 
properly in the Xenopus oocyte. To determine whether the observed issues were specific to the oocyte 
model system, a series of experiments were performed in mammalian cells.   
1.3.3 Mammalian Cell Experiments 
For initial experiments, two different mammalian cell lines were chosen: HEK-293T cells and MDA-
MB-231 cells. Although neither of these cell lines has previously been used to study RARα – as much of 
the work done with RARα had been related to cell cycle regulation and thus done in complicated cell 
lines such as chondrocytes – each offers distinct advantages in terms of the experimental set up.38 The 
HEK-293T cells offer genetic tractability. Given that RARα, RXRα, and the RARE-Luc reporter plasmid 
must all be present in the same cell (as well as any tRNA that is to be incorporated) if a signal is to be 
observed, a system which boasts robust transfection efficiency will likely be more effective for the 
proposed experiments.39 The HEK-293T cells also offer amenability to noncanonical amino acid 
incorporation; enzymatic acylation has previously been used to incorporate a number of exogenous 
amino acids into the cell line.40 Although chemical acylation in the cell line has yet to be described, 
previous attempts by the Dougherty group provide a starting point for further investigation.41 MDA-
MB-231 cells lack the high expression efficiencies that characterize the HEK-293T cell line, but they offer 
Figure 16: RT-qPCR with a genuine intron-3 RARE-Luc.  
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low levels of native RARα expression (Figure 17).31 
Given that the inconsistency in the oocyte model system 
may be due to endogenous RARα activity, having a 
system with low RARα expression offers a potential 
experimental advantage. In addition to selecting 
appropriate cell lines, a new reference gene was selected, 
ubiquitin C (UBC), as it’s use was well characterized in 
mammalian cells lines.42  
To probe the ability of each cell line to serve as a potential model system, a number of controls were 
run. First, RNA from naïve cells was isolated from each cell line, and RT-qPCR performed to ensure that 
the luciferase qPCR primers did not amplify native genetic material. No amplification was observed in 
either cell line. This prompted experiments to test the transcriptional activity of native RARα. Although 
such activity was expected to be negligible in the MDA-MB-231 cell line, the significance of background 
transcription in the HEK-293T cell line was unclear. Briefly, cells were transfected with the RARE-Luc 
primer, given 24 hours to recover, incubated with 10 μM ATRA or vehicle overnight, then processed 
similarly to oocytes for RT-qPCR. Although signal was observed in both cases, the use of no RT controls 
demonstrated that this was due to DNA contamination, and that true background transcription was 
negligible for both cell lines (Figure 18). This suggested either cell line could be used for future 
Figure 17: Expression of RARα in different 
cell lines. Adapted from Lu et al.31 
Figure 18: Background RT-qPCR activity in HEK-293T cells.  
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experiments. Due to the robust nature of HEK-293T cells, from this point forward most optimization 
was performed in this cell line.  
Following demonstration of negligible background signal, a basic transcriptional experiment was 
performed in each cell line. Both HEK-293T and MDA-MB-231 cells were transfected with pGL3 
RARE-Luc, pcDNA6 RARα, and pSV SPORT RXRα (where pXX represents an expression vector). 
Transcriptional activity was evaluated using qPCR. In both cell lines, no transcriptional activation was 
observed using these constructs. Although the reasons for this result were unclear, one potential 
possibility was inefficient transfection. To control for this, an experiment was performed in which HEK-
293T cells were incubated with the RARE-Luc reporter plasmid but no transfection reagent. When an 
RT-qPCR analysis was performed on these cells, no DNA background signal was observed. This 
suggested that previously observed DNA contamination was present due to transfection of the reporter 
plasmid into cells, and therefore transfection inefficiency was ruled out as the cause of transcriptional 
failures. 
Another potential possibility was poor expression 
of the nuclear receptors. To investigate this possibility, 
a western blot was run using HEK-293T cells 
transfected with RARα. No expression was observed 
using either an anti-His6 or an anti-FLAG primary 
antibody (Figure 19A), suggesting poor RARα 
expression was at least partially responsible for the lack 
of transcriptional activation. In an effort to improve 
expression, the RARα gene was subcloned from the 
pcDNA6 vector into a new expression vector, 
pcDNA3.1. This vector has been shown to produce 
high levels of protein expression in HEK-293T cells.34 
Although an anti-His6 western blot did not 
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Figure 19: RARα production in HEK-293T 
cells. A.) Lanes 1 and 2 represent naïve and 
pcDNA6 RARα-transfected cells. The lack of 
difference between the lanes suggests RARα is 
not being expressed. Visualized using an anti-
His6 antibody. B.) Lane 3 represents naïve cells 
probed with anti-FLAG, while lane 4 represents 
pcDNA3.1 RARα transfected cells.  
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conclusively demonstrate that this solved expression problems, stripping the membrane and reprobing 
with anti-FLAG antibody revealed a significant improvement in expression (Figure 19B). Since RXRα 
lacked an affinity tag to validate expression in the pSV SPORT vector, it was also subcloned into the 
pcDNA3.1 vector to ensure expression.  It is worth noting that although RXRα expression is expected 
to enhance the observed signal, RXRα was not included in older experimental protocols, therefore the 
inability to ensure expression, while inconvenient was not debilatating.43 
Having established RARα expression, basic transcriptional experiments were performed in HEK-
293T cells, this time in conjunction with western blot analysis of ATRA-treated and vehicle-treated cells. 
Once again, transcriptional activation was not observed. However, the results of the western blot were 
notable. The vehicle treated cells demonstrated significant 
protein expression, but treatment with ATRA led to a complete 
ablation of RARα signal (Figure 20). Although the magnitude of 
this response was somewhat unexpected, it has been previously 
observed that ATRA can regulate RARα degradation.44 Given 
that complete degradation of RARα would preclude any RARα 
mediated transcription, conditions were screened to determine 
incubation conditions that did not result in complete 
degradation of the protein. After screening a number of different 
incubation times and ATRA concentrations, a one hour 
incubation using 1μM ATRA was selected for further 
experiments.   
With this new set of incubation conditions, basic transcriptional experiments were once again 
performed, in both HEK-293T cells and MDA-MB-231 cells. Western blots were used to verify protein 
production in the HEK-293T cells. Despite the revised incubation conditions, transcriptional activity was 
not observed. This suggested that RARα degradation was not entirely responsible for the lack of observed 
signal.  
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Figure 20: RARα production in 
the presence of ATRA. Lanes A 
and B are positive and negative 
controls, respectively. Lane C 
contains RARα transfected cells 
incubated with ATRA and lane D 
contains RARα transfected cells 
incubated with vehicle.  
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As a final attempt to obtain a positive control, the amount of transfected material was doubled. 
Although this led to decreased cell health (as evidenced by morphology and plate adherence), it ultimately 
resulted in transcriptional activation and a ΔΔCq of greater that one (Figure 21). Analogous to the Xenopus 
oocyte experiments, the exact value of the ΔΔCq was inconsistent between runs. This suggested a more 
fundamental issue with the RARα/RXRα experimental setup, one that was unrelated to choice of model 
system. 
1.3.4 Exploration of the Role of P78 
Despite the consistent difficulties of working with the RARα/RXRα model system, an experiment 
was devised to evaluate the role of proline 78 in regulating RARα transcriptional activation. This 
experiment was carried out in the Xenopus oocyte model system. Serine 77 in RARα was mutated to an 
alanine (S77A) to test the idea that P78 was a target for Pin1 dependent isomerization. Specifically, it was 
hypothesized that ablation of the phosphorylation site at S77 would lead to complete interruption of Pin1 
isomerization at P78 and disruption of subsequent transcriptional activity. This would lead to a ΔΔCq of 
approximately zero. Surprisingly, the S77A mutant produced a negative ΔΔCq, suggesting that S77 itself 
was regulated by ATRA (Figure 22). This led to an inconclusive result regarding the role of P78 in RARα 
Figure 21: Transcriptional activation in HEK-293T cells. A doubling of 
transfected material was required to obtain transcriptional activation.  
 
NoRA ΔCq= 1.60 
RA ΔCq= 2.72 
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activation and suggested that further experiments would require a better experimental setup and should 
focus specifically on proline 78. Towards this end, a luciferase assay was explored as an alternative to RT-
qPCR.  
1.3.5 Evaluation of P78 Using a Luciferase Assay 
 In a final attempt to explore the effect of proline 78 on RARα regulation, a luciferase assay was 
designed to circumvent the issues associated with RT-qPCR. Cells were transfected as they were for the 
RT-qPCR experiments, but a renilla luciferase control plasmid was added so that the luminescence 
intensities could be normalized. After a 24 hour incubation, cells were lysed using a buffer compatible 
with luminescence evaluation. Cell lysates were then mixed with a luciferase assay buffer, plated into a 96 
well plate, and evaluated for luminescence using a Flexstation 3. The luminescence of the control 
luciferase was also recorded. Using this method, it was observed that the RARE-Luc construct had little 
signal independently, but significant signal when used in the presence of ATRA and RARα (Figure 23). 
Given this significant improvement in signal relative to the RT-qPCR assay, a P78TAG mutant of RARα 
was generated to assess the role of P78 in RARα transcriptional regulation. As expected, this mutant led 
to complete ablation of luciferase activity in the absence of complementary tRNA. Unfortunately, 
attempts at recovering WT activity with a proline-modified tRNA were inconclusive. Some initial positive 
results using chemically acylated tRNA were quickly brought into doubt when significant recovery was 
Figure 22: Transcriptional suppression in S77A RARα. 
 
NoRA ΔCq= 2.44 
RA ΔCq= .97 
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observed using unacylated tRNA (76mer). This suggested than any signal increase that was observed 
could be due to the acylation of tRNA inside the cell. Furthermore, the signal obtained with unacylated 
tRNA was significantly greater than that of acylated tRNA charged with either a proline (WT recovery) 
or a proline derivative (Figure 24), suggesting that enzymatic reacylation was the most significant factor 
in any observed signal. In an attempt to address this issue, a screen was run using a number of full length 
tRNAs from different origins. Unfortunately, none of these gave better results than THG73 76mer, 
suggesting that the issue could not be resolved by using an alternative tRNA.  
Figure 23: Luciferase expression in the presence of ATRA and RARα.  
 
Figure 24: 76mer, THG73-Pro, and THG73-Pip incorporation into P78TAG 
RARα. The structures of the Pip and Pro amino acids are shown. 
 
Pro 
Pip 
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The reason that chemically acylated tRNA failed to give significantly higher signal than unacylated 
tRNA remains unresolved. It could be a transfection failure or a translation failure, but ultimately this 
prompted a different question: can chemically acylated tRNA be efficiently introduced into mammalian 
cells? This question took precedence over investigation of the role of P78 in the RARα transcriptional 
pathway, and ultimately led to a halt in the project  
1.4 Conclusion 
The regulation of transcription factors remains an incredibly important issue. They play a significant 
role in many diseases, and a large portion of them are considered undruggable.  Unfortunately, despite 
significant efforts to develop and optimize an RT-qPCR assay for studying nuclear receptors in the 
context of noncanonical amino acids, a reliable assay could not be developed. The reproducibility issues 
encountered in oocytes and the inability to efficiently introduce chemically-acylated tRNA into 
mammalian cells mean that the promise of this project cannot be capitalized on at this point. This project, 
however, remains a worthwhile intellectual endeavor, and as better transfection reagents are developed 
attempts to study nuclear receptors using noncanonical amino acids in mammalian cells should be 
reconsidered.  
1.5 Materials and Methods 
1.5.1 Materials 
 pSV Sport RXR (ID: 8882), pcDNA6 FLAG-RAR (ID: 35555), and pGL3 RARE Luciferase (ID: 
13458) constructs were obtained from Addgene. All-trans retinoic acid (ATRA) was purchased as a 
powder from Sigma, suspended as a 10 mM stock in DMSO and stored at -80 °C. HEK-293T cells were 
obtained from frozen stocks, previously purchased from ATCC. MDA-MB-231 cells were obtained as a 
gift from the Dervan group.   
1.5.2 Preparation of Oocytes 
 Harvested stage V–VI Xenopus oocytes were washed in four changes of Ca2+-free OR2 buffer 
(82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH = 7.5), defolliculated in 1 mg/mL 
collagenase for approximately 1 h, washed again in four changes of Ca2+-free OR2 and transferred to 
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ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, pH = 7.5) supplemented 
with 0.28 mg/mL pyruvate, 0.05 mg/mL Gentamicin, and 0.12 mg/mL theophylline. Oocytes were 
injected with either cDNA plasmids or mRNA produced by in vitro transcription using the mMESSAGE 
mMACHINE kit (Ambion, Austin, Texas, USA) from cDNA subcloned into pGEMHE. 
 Oocyte nuclei were injected by allowing the nucleus to rise against the animal pole. Oocytes were 
injected deeply and directly into the center of discolored regions the animal pole that appeared after such 
incubation with 2 ng of reporter plasmid per oocytes (varying amounts were used for injection screens). 
Oocyte cytoplasms were injected shallowly at the edge of the animal pole with 10 ng of mRNA for each 
transcription factor (varying amounts were used for injection screens). 24 hours after the second injection, 
oocytes were incubated with ATRA or vehicle overnight in a blacked out container. 
1.5.3 Cell Culture and Harvesting Techniques 
MDA-MB-231 (gift of the Dervan lab) cells were cultured in high glucose DMEM (Sigma) with 10% 
FBS (Sigma) and 1% Pen/Strep (Sigma) in a 5% CO2 atmosphere at 37 °C. HEK-293T cells (ATCC) 
were cultured in DMEM:F12 (1:1) with GlutaMax-1 (Gibco) with 10% FBS (Sigma) and 1% Pen/Strep 
(Sigma) in a 5% CO2 atmosphere at 37 °C. Cells were cultured using 100 mm cultures dishes (Corning), 
and split to 35 mM dishes (Corning) for experimental purposes. Cells were passaged at approximately 
80% confluency. For each cell line, passaging procedures were similar, differing only in the media used. 
Passaging was performed by removing the media from the cells, washing with PBS (10 mM Na3PO4, 150 
mM NaCl, pH 7.8), and adding TrypLE. Cells were incubated for 5 minutes, at which point detachment 
was verified by microscopy. 9 mL of fresh media was then added to quench the TrypLE. Cells were 
resuspended until homogenous. New plates were seeded at a 1:10 dilution factor for the HEK-293T cells 
and a 1:5 dilution factor for the MDA-MB-231 cells. 
 For experiments, cells were transfected using either PEI (Sigma) or Xfect (Clontech, now Takara Bio). 
For PEI, 1.5 μL of DNA and 9 μL of a 1 mg/ml solution of PEI were added to 300 μL of media lacking 
FBS and pen/strep. After 10 minutes, this was diluted to 3 mL of media total, and added to cells 
overnight. After washing with PBS, fresh media was added in the morning to stimulate growth. For Xfect, 
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0.3 μL of Xfect polymer was added per 1 μg DNA to 100 μL of Xfect buffer. This solution was incubated 
for 10 minutes, then added directly to cells. After 4 hours, cells were washed and the media replaced. 
Transfected cells were given 24-36 hours to produce protein, at which point they were incubated with 
ATRA or vehicle. For harvesting, cells were washed with PBS, detached using TrypLE, and then 
resuspended using media. The resulting solution was spun down, the media was removed, cells washed 
once more with PBS, and then the appropriate lysis buffer was added depending on the assay. 
1.5.4 RNA Isolation and Reverse Transcription 
RNA isolation was performed using RNeasy kit (Qiagen). Deviations from standard protocol are 
detailed below. For oocytes, four oocytes were lysed in 350 μL buffer RLT and vortexed to homogenize 
until no macroscopic oocyte structure remained intact. For mammalian cells, harvested cells were lysed 
in 350 μL buffer RLT and sheared by needle and syringe to ensure lysis. Ethanol precipitation proceeded 
directly on either lysed sample without centrifugation. 8 L DNAse I in an 80 L buffered solution 
(Roche or Qiagen) was applied to the column and incubated at room temperature for 15 minutes. RNA 
was eluted in 20 L of RNAse-free water. This eluent was then passed through the column a second time 
for complete recovery. Samples were stored at -80 °C until ready for reverse transcription.  
 Reverse transcription was performed using the Transcriptor First-Strand cDNA Synthesis kit (Roche). 
Deviations from standard protocol are detailed below. 1 g (initially 2 μL) of total RNA extract was 
added to a 20 L reaction containing polythymine [dT]18 primer. RNA, primer, and water were denatured 
at 65 ºC for 10 minutes and cooled on ice before the addition of buffer, dNTPs, RNase inhibitor and 
reverse transcriptase in a master mix. This reaction was incubated for 30 min at 50 °C before transcriptase 
denaturation by incubation at 85 °C for 5 min. 
1.5.5 Quantitative Polymerase Chain Reaction 
20 L qPCR reactions employed the 2X SYBR Green Master Mix (Roche). 1.25 L each from 10 
M forward and reverse primer stocks was added along with 2 L from the reverse transcription reaction. 
DNA obtained from the RT reaction was used to seed luciferase and reference gene reactions. Each 
condition was run in triplicate.  
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 18 L of each sample was transferred to a 96-well plate taking care to avoid bubbles, covered, and 
run on a Bio-Rad CFX96 Real-Time system qPCR with a 2-step cycle. An initial denaturation of 95 °C 
for 10 minutes preceded 40 cycles of 10 seconds at 95 ºC and 30 seconds at the annealing temperature 
(63.5 °C for the luciferase reactions, 48 °C for all reference genes). A fluorescence measurement was 
taken at the end of each cycle. Following the final cycle, a temperature gradient ramping from 58 – 88 
°C, raising two degrees per minute, was run.  
1.5.6 Western Blot 
 Both oocytes and mammalian cells were lysed in radioimmunoprecipitation assay buffer (50 mM Tris 
pH 8, 150 mM NaCl, .1% SDS, .5% sodium deoxycholate, 1% Triton X, protease inhibitor tablet 
(Roche)) with 50 μL being used per oocyte and 200 μL for a harvested 35 mm plate of cells. Oocytes 
were lysed by vortexing, mammalian cells by needle and syringe. Cell lysates were spun down for 20 
minutes at 4°C, and the supernatant isolated. Prior to loading onto a polyacrylamide “Any-kD” gel (Bio-
Rad), lysate was mixed with 4X SDS-loading buffer (100 mM Tris pH 6.8, 4% SDS, .2% bromophenol 
blue, 20 % glycerol, 200 mM DTT). Unused lysate was flash frozen using liquid nitrogen. Gels were run 
for ~50 minutes using SDS-running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) before being 
transferred to Immun-blot® LF PVDF (Bio-Rad) using a wet transfer technique.42 The PVDF was 
blocked for 1 hour using 5% evaporated milk (Carnation) in TPBS (10 mM Na3PO4, 150 mM NaCl, pH 
7.8, .1% Tween), then  incubated for 1 hour in 5% evaporated milk in TPBS with a 1:1000 dilution of 
anti-His6 antibody (Pierce) or a 1:5000 dilution of anti-FLAG antibody (gift of the Hsieh-Wilson group). 
The membrane was washed 4 times with TPBS, incubated for another hour with 5% evaporated milk in 
TPBS with a 1:3000 dilution of goat anti-mouse 680 antibody (Life Technologies), then washed 3 more 
times. Blots were visualized using the Odyssey imaging apparatus (Licor). 
1.5.7 Luciferase Assay  
Luciferase assays were performed using the luciferase assay system (Promega). Following transfection 
and treatment with the either ATRA or vehicle, cells were lysed using the cell culture lysis reagent 
(Promega). Briefly, 300 µL of Cell Culture Lysis Reagent (Promega) was generated from a 5X stock for 
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each plate of cells to be lysed. This solution was then pipetted vigorously with the cells. Once all cellular 
material was suspended, the solution was transferred to an Eppendorf tube and allowed to rock for 15 
minutes at 4° C. This solution was then spun down at 10,000 g, and the supernatant used to seed a 
luminescence assay. Specifically, 60 µl of the lysis solution was added to 300 µl of luciferase assay reagent 
(Promega). From this solution, three 100 µL aliquouts were removed for analysis by a 96-well plate 
luminescence assay using a Flexstation 3 (Molecular Devices). After assessing the firefly luciferase signal, 
Stop and Glo buffer (Promega) was added to quench the firefly luciferase signal and initiate the renilla 
luciferase signal. The renilla luciferase luminescence was then recorded using a Flexstation 3 (Molecular 
Devices). The triplicates were averaged and standardized against the renilla luciferase signal for a final 
luminescence value.  
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Chapter 2: Further Work on the Use of Chemical Acylation for Noncanonical Amino 
Acid Mutagenesis in Mammalian Cells 
 
2.1 Abstract 
 Chemically acylated tRNA is a powerful tool for introducing novel functionality into proteins. 
Unfortunately, expanding its use beyond the study of ion channels in Xenopus laevis oocytes has proven 
particularly challenging. Described herein are attempts at expanding the methodology into mammalian 
cells, first in nuclear receptors and then in luciferase proteins. Nuclear receptors were initially chosen due 
to the signal amplification they provide upon transcription and their relevance in cell biology. Estrogen 
receptor alpha was chosen specifically as its activity is well characterized in the literature. Following 
unsuccessful attempts at recovery of transcriptional activation, a simpler system was devised based on a 
TAG mutant of Renilla luciferase. In this system, incorporation of a noncanonical amino acid was directly 
correlated with an observable luminescence. Unfortunately, luminescence recovery was also unsuccessful, 
suggesting a more fundamental issue with the system. Attempts were next made to control the pathways 
responsible for tRNA stability, both by upregulation of the stabilizing protein elongation factor 1a and 
the (suspected) destabilizing protein BPNT1. Despite efficient upregulation and suppression of these two 
proteins, respectively, no luminescence recovery was obtained following transfection with chemically 
acylated tRNA.   
2.2 Introduction 
2.2.1 The Chemical Acylation Methodology and Mammalian Cells 
 As mentioned in chapter 1, noncanonical amino acid incorporation is an extremely powerful tool for 
studying and manipulating proteins. This can be performed in one of two ways: site-specific incorporation 
or residue-specific incorporation. Each method offers unique advantages, and together they provide a 
robust toolset for studying proteins.1 Of the two, site-specific incorporation via nonsense suppression 
has been of particular interest in our lab, as we are interested in studying chemical scale interactions in 
proteins such as ion channels.2 There are two methods to acylate the tRNA used for nonsense 
suppression. The first, enzymatic acylation, has found widespread use. It is robust, offers high yields, and 
requires only a catalytic amount of tRNA.3 Despite the many strengths of this method, it is limited by the 
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need for a unique synthetase for each amino acid to be used. The second method, chemical acylation, is 
a complete foil to enzymatic acylation. It is much less robust and requires a stoichiometric amount of 
tRNA, however, it can be used to easily install any amino acid that is accepted by the ribosome.2 
 Our lab has used the flexibility of chemical acylation methods to explore a range of phenomena in 
ion channels in the Xenopus laevis oocyte. Electrostatic interactions via fluorinated aromatic amino acids, 
cis-trans preferences via proline analogs, and backbone interactions via α-hydroxy acids have all been 
probed.2,4 The choice of protein class and model system abrogates the weaknesses of the chemical 
acylation method, ultimately producing a robust assay. Unfortunately, it has been difficult to expand the 
methodology. Some success was found studying GPCRs in Xenopus oocytes using an ion channel linked 
assay. However, beyond this no other class of proteins has been explored outside a test tube.5,6 Chapter 
1 dealt with attempts to expand the methodology to another set of proteins, nuclear receptors. This 
chapter discusses attempts to expand the system to a model system besides Xenopus oocytes, as different 
model systems could confer unique advantages. Specifically, studying ion channels in their native 
environment, mammalian cells, could yield new insights into function.  
 Introduction of acylated tRNA into mammalian cells is significantly more complicated than it is in 
Xenopus oocytes. Due to the large size of the Xenopus oocyte, tRNA can be physically injected, ensuring 
delivery of tRNA. For mammalian cells, tRNA must be introduced the same way as any other RNA – 
through transfection or electroporation. These methods are less reliable than physical injection, and each 
provides a host of technical challenges. Previous work in our lab has tested both methods. Work by Sarah 
Monahan demonstrated the successful incorporation of a fluorinated derivative of tryptophan using 
electroporation.7 Despite this initial success, the method was found to be unreliable and resource 
intensive, requiring a significant amount of acylated tRNA for each electroporation. This work was 
followed by exploration of transfection based methods by Kristina Daeffler and Nyssa Puskar.8  
 Daeffler and Puskar screened a number of conditions using different transfection reagents, but they 
were ultimately unable to incorporate a noncanonical amino acid by transfecting acylated tRNA. They 
were, however, able to make some progress in optimizing transfection conditions using the tRNA known 
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as the human serine amber suppressor (HSAS). This tRNA is enzymatically acylated in human cells by 
the serine synthetase, however, it recognizes an amber stop codon rather than a traditional serine codon 
and therefore can be used for nonsense suppression. 9 This allowed the duo to evaluate conditions where 
tRNA transfection was occurring at levels too low to give a stoichiometric readout and optimize 
conditions for the transfection of chemically acylated tRNA. Although Daeffler and Puskar were unable 
to transfect acylated tRNA, the conditions they devised using HSAS tRNA provide important 
groundwork for continued experiments.  
 Ion channels provide sufficient signal amplification for studies in oocytes, however, it is possible that 
they are an inappropriate readout for mammalian cells, particularly for the experiments carried out by 
Daeffler and Puskar. In these experiments, transfected cells were plated into 96 well plates and incubated 
with a voltage-sensitive fluorescent dye.8 Drug was then applied, and an increase in fluorescence was 
observed depending on the efficiency of ion channel opening.8 Although this assay worked reasonably 
well for wild type ion channels, insufficient signal was obtained when it was used with chemically acylated 
tRNA. The fluorescent turn-on failed to provide a comparable amount of signal amplification as 
electrophysiology, and thus was an insufficient readout for the low protein yields associated with the 
nonsense suppression methodology. 
 Going forward, a different readout is required, one that offers significant signal amplification. 
Transcription and translation both amplify a chemical signal, making transcription factors a good target 
for a new assay. Furthermore, by selecting an appropriate gene, synthesized protein can provide additional 
signal amplification. For this reason, an assay linking a transcription factor to expression of a catalytic 
reporter protein was designed. As the basis for this new assay, estrogen receptor alpha (ERα) was chosen 
as the transcription factor and luciferase as the reporter protein. 
2.2.2 Estrogen Receptor Alpha  
 ERα is a member of the nuclear receptor superfamily, and it is one of two nuclear receptors that binds 
estrogen, with the other being estrogen receptor beta (ERβ).10 It is an extremely well-studied protein due 
to its association with a number of biological events, making it a good target for assay development. The 
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receptor binds an endogenous set of hormones known as estrogens, however, it is fairly promiscuous, 
also binding a myriad of other compounds, some of them bearing little resemblance to estrogen.10 
Classically, binding of estrogen to ERα was thought to induce dimerization of the receptor (either with 
ERα or ERβ), translocation of the dimer to the nucleus, DNA binding, and transcriptional activation. 
Although through the years it has been shown that this is somewhat of an oversimplification, what 
remains fundamentally true is that ERα ligand binding induces recruitment to transcriptional activator 
elements known as estrogen response elements (EREs).10 These response elements vary significantly in 
composition, however, the core consensus sequence usually consists of a thirteen base pair palindromic 
repeat.11A number of plasmids have been developed containing estrogen response elements, with a 
variety of different genes linked to the response element. Luciferase is a particularly attractive gene, as it 
offers additional signal amplification in the form of its chemilumescence readout.   
 To use a combined ERα/luciferase assay to test tRNA transfection techniques, an ERα TAG mutant 
was required; judicious selection of the site required an analysis of the protein’s entire structure. ERα is a 
multi-domain protein consisting of an N-terminal domain, a DNA binding domain, a hinge region, a 
ligand binding domain, and a C-terminal domain, all of which play important roles in the regulation and 
activity of the protein.10 The DNA binding domain and ligand binding domain have been well 
characterized structurally, however, the N-terminal domain, C-terminal domain, and hinge region have 
been difficult to characterize due to their intrinsic disorder. This makes them ideal targets for the chemical 
scale analyses performed in the Dougherty lab, therefore these regions were initially targeted for the 
development of TAG mutants. Ultimately, a 
C-terminal mutant at tyrosine 526 was 
generated for initial experiments. This location 
was selected for two reasons. For one, 
replacement of a tyrosine with fluorinated 
phenylalanine derivatives is routinely done in 
our lab, making tyrosine a good amino acid for 
Y526 
Figure 1: Potential cation-pi interaction in ERα. 
Positioning of Y526 and a nearby arginine in the 
agonist bound form of ERα. 
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initial replacement experiments. In addition, in the agonist bound form Y526 appears to be interacting 
with a nearby arginine (Figure 1), making a cation-pi interaction worth 5.1 kcal/mol according to the 
Cation-π Trends Using Realistic Electrostatics (CaPTURE) computational method.12 In the event that 
incorporation is successful, this interaction could be probed as a true proof of concept.  
2.3 Results and Discussion 
2.3.1 TAG Suppression Attempts in Estrogen Receptor Alpha 
 To begin developing a more efficient assay for tRNA incorporation in mammalian cells, two plasmids 
were ordered from Addgene, one containing an eGFP-ERα construct and the other containing a 3X 
Estrogen Response Element coupled to a luciferase reporter. Initial experiments with these two 
constructs and β-estradiol (an estrogen) in HEK-293T cells demonstrated low background signal in the 
absence of estradiol and a nearly 4-fold transcriptional activation when a sufficient amount of eGFP-ERα 
DNA was transfected (Figure 2). Inherent transcriptional activation in the absence of estradiol suggests 
that either estrogens within the cell are regulating the ERα or that activation of ERα is occurring through 
Figure 2: ERα transcriptional activation in the presence of E2. Evaluated by luminescence response. 
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other pathways, a phenomenon  that has previously been described.13 Despite some inherent background, 
this activation was considered sufficient enough to warrant studies with mutant estrogen receptors.  
As mentioned in the introduction, the initial site selected for mutation was Y526. Three mutants were 
made. Y526F and Y526A were generated to probe the sensitivity of the site to mutation, and Y526TAG 
was made for noncanonical amino acid mutagenesis experiments. Evaluation of Y526F and Y526A 
demonstrated that Y526 did not play a significant role in estrogen receptor activation, invalidating the 
proposed cation-pi theory. The results did not totally discourage exploration of the site, however, as 
Y526TAG demonstrated complete ablation of activation (Figure 3.) Based on these results, incorporation 
of chemically acylated tRNA was attempted, using THG73 76mer as a control. These results were 
significantly less encouraging, as only a small amount of recovery was observed using chemically acylated 
tRNA (either the F4-Phe unnatural or Tyr wild type recovery), with much greater signal being observed 
with the 76mer control (Figure 4). To determine whether or not this recovery was specific to the control 
used, a number of other control tRNAs were evaluated (TQAS 76mer, TQOPS’ 76mer, THG73 
7474mer). Although none gave as large a response as THG73, they all gave a larger result than the 
chemically acylated tRNAs tested, suggesting reacylation at the site was a significant issue. Interestingly, 
Figure 3: Evaluation of Y526 as a sight for further experiments.  
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when a protein gel was run to look for full length protein from the Y526TAG mutant transfected with 
THG73 76mer, only truncated product was observed, suggesting that observed signal increase was not 
due to the presence of full length protein, but perhaps an artifact of transfection.  
 To account for the possibility that the results obtained for Y526TAG ERα were a consequence of the 
site used, a number of other mutants were explored. One mutant, Y43TAG, gave significant activation 
in the presence of E2 and was avoided. The other two, Y191TAG and Y248TAG, had higher mutant 
background signal than Y526, but no notable activation in the presence of THG73 76mer. These two 
mutants were transfected with chemically acylated tRNA, but no activation was observed above 
background (Figure 5). Although additional sites could be explored, the results suggested that combined 
transcriptional-luciferase readout was too complicated, and that optimization of chemically acylated 
tRNA incorporation should be performed in a simpler system. To reduce the number of transfected 
plasmids as well as the number of steps between amino acid incorporation and readout, a Renilla luciferase 
containing a TAG mutation was explored. 
 
 
Figure 4: Chemical acylation incorporation attempts. Notably, the 76mer control gives greater 
luminescence signal than either of the two chemically acylated tRNA. 
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2.3.2 TAG Suppression Attempts in Renilla Luciferase 
 Starting with a plasmid from Addgene containing a constitutively expressed wild type Renilla luciferase 
(pRL-SV40P), an F49TAG mutant of Renilla luciferase was generated. As expected, this mutant was 
completely inactive. Recovery was subsequently attempted with THG73 alpha hydroxy phenylalanine, as 
it has been demonstrated that alpha hydroxy acids typically give higher incorporation efficiency than 
corresponding amino acids using the chemical acylation method.14 Unfortunately, the mutant could not 
be rescued by either THG73 76mer or THG73 acylated with alpha hydroxy phenylalanine (Figure 6). 
Rescue with a pyrrolysine derived tRNA was next attempted15,16, followed by rescue using a different 
transfection reagent (Effectene). Neither attempts were successful. As a last resort, another mutant 
(Y6TAG) was generated, but this mutant was also not responsive to transfection of chemically acylated 
tRNA. These results suggested that a more fundamental issue existed regarding tRNA transfection, and 
that a different approach was required. Towards this end, the literature regarding tRNA transfection was 
reevaluated.  
Figure 5: Transfection attempts using Y248TAG mutant of ERα. 
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 The literature is fairly divided on the fate of transfected tRNA in a cell. Although some groups have 
observed successful incorporation of endogenously introduced tRNA into a cell’s tRNA pool (our group 
included), others have observed significant degradation of introduced tRNA. It is likely that these two 
outcomes are both possible, but the pathway that predominates is circumstantial.7,17,18 There are two ways 
that one could consider biasing this pathway. The first would be to overexpress proteins involved in 
tRNA stabilization. Elongation factor 1a (EF1a) is one of the predominant proteins known to do this, 
rescuing tRNA from degradative pathways.19,20 The second would be to knock down pathways associated 
with tRNA degradation. Although there are multiple pathways for degradation, one of the most 
significant in yeast is known as the tRNA Rapid Decay Pathway, which reduces the half-life of tRNA to 
about 15 minutes under conditions of stress, such as transfection.19,21 Although this pathway has not been 
characterized in mammalian cells, a set of homologous proteins exists, predominant among which is 
BPNT1.  
 Both EF1a overexpression and BPNT1 knockdown were explored as ways to regulate tRNA stability 
in transfected cells. For EF1a overexpression, a plasmid containing eEGFP-eEF1a was obtained from 
Figure 6: F49TAG Renilla luciferase recovery attempts. 
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the Nudler lab at NYU. Overexpression was monitored by eGFP fluorescence using either the 
Flexstation or gel electrophoresis in combination with a Typhoon fluorescence imager. Once 
overexpression was validated, transfection conditions were optimized and F49TAG Renilla luciferase 
recovery experiments were attempted. 
Unfortunately, overexpression of EF1a had 
no notable effect on luciferase recovery 
(Figure 7). For BPNT1 knockdown, 
BPNT1 siRNA and a BPNT1 antibody 
were ordered from Santa Cruz Biotech. 
Expression of BPNT1 was then evaluated 
under knockdown conditions, using tubulin 
to control for protein expression and 
blotting efficiency (Figure 8). The results of 
the knockdown experiment suggested that 
suppression of BPNT1 expression was 
Figure 8: BPNT1 knockdown with BPNT1 siRNA. Lane 
1 contains WT HEK-293T lysate and lane 2 contains BPNT1 
knockdown (6 pm BPNT1 siRNA) HEK-293T lysate.  
Figure 7: Effects of EF1a overexpression on F49TAG Renilla luciferase recovery. 
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indeed possible, although higher concentrations (>10 picomoles) would be required to obtain significant 
knockdown. Knockdown was subsequently attempted in the context of F49TAG Renilla luciferase 
recovery, but no significant change was observed (Figure 9), even with greater than 70% BPNT1 
knockdown. One last attempt was made incorporating both EF1a overexpression and BPNT1 
knockdown, but once again no recovery was observed.  
At this point, noncanonical amino acid incorporation via enzymatic methods was attempted to ensure 
that recovery at the mutant was possible. The use of a synthetase and media containing p-
azidophenylalanine led to recovery of activity, albeit at about 15% of the wild type levels. Still, this 
demonstrated that rescue was possible and that F49TAG could not be entirely blamed for the failure of 
the method.  
 Having explored most other conditions, it seems that transfection conditions are likely responsible 
for the poor incorporation/uptake of the tRNA. A number of conditions had been evaluated by Daeffler 
and Puskar, but none stood out as exceedingly better. This suggests that the current generation of 
transfection reagents is insufficient for the efficient transfection of tRNA and that further progress is 
dependent on the development of novel transfection reagents. Monahan’s results were predicated on 
Figure 9: Effects of BPNT1 knockdown on F49TAG Renilla luciferase recovery. 
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electroporation, which may be the only method that is currently capable of incorporating chemically 
acylated tRNA into mammalian cells. Unfortunately, this method is too impractical to use beyond proof 
of concept experiments.  
2.4 Conclusion 
 Significant effort was made to expand the use of chemically acylated tRNA into mammalian cells. 
Initial attempts were made in the context of nuclear receptors, which have the potential to provide 
significant signal amplification and are integral to a number of complex cellular pathways.  After recovery 
could not be achieved in nuclear receptors, the system was simplified to reduce the number of steps 
between amino acid incorporation and readout. Although this led to cleaner controls and lower 
background, recovery was still not observed. Finally, cell biology was manipulated in an attempt to 
stabilize the transfected tRNA. This was done through upregulation of a stabilizing pathway and down 
regulation of a suspected destabilizing pathway. Neither of these led to recovery, suggesting that a more 
fundamental issue exists, likely with regards to the transfection reagent. Although progress in this project 
has been halted for the time being, novel transfection reagents – like those produced in the Waymouth 
and Wender groups at Stanford – are likely to reinvigorate exploration of this challenging topic. 
2.5 Materials and Methods 
2.5.1 Materials  
 HA-ERα, estrogen response element, and Renilla luciferase constructs were obtained from Addgene 
(pcDNA-HA-ER WT, 3X ERE TATA.luc, and pRL-SV40P respectively). An eGFP-eEF1a1 construct 
was obtained from the Nudler lab at NYU. Estradiol was purchased as a powder from Sigma-Aldrich. 
BPNT1 siRNA and mouse anti-BPNT1 antibody were obtained from Santa Cruz Biotech.  Mouse anti-
tubulin antibody was obtained from Sigma Aldrich.  
2.5.2 Mammalian Cell Culture 
HEK-293T cells (ATCC) were cultured in DMEM:F12 (1:1) with GlutaMax-1 (Gibco) with 10% FBS 
(Sigma) and 1% Pen/Strep (Sigma) in a 5% CO2 atmosphere at 37°C. Cells were cultured using 100 mm 
culture dishes (Corning), and split to 35 mM dishes (Corning) for experimental purposes. Cells were 
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passaged at approximately 80% confluency. Passaging was performed by removing the media from the 
cells, washing with PBS (10 mM Na3PO4, 150 mM NaCl, pH 7.8), and adding TrypLE. Cells were 
incubated for 5 minutes, at which point detachment was verified by microscopy. 9 mL of fresh media 
was then added to quench the TrypLE. Cells were resuspended until homogenous. New plates were 
seeded at a 1:10 dilution factor for the HEK-293T cells. 
 For experiments, cells were transfected using Xfect, RNA Xfect, or a combination of the two 
depending on the transfection being performed (Clontech, now Takara Bio). For DNA Xfect 
transfections, 0.3 μL of Xfect polymer was added per 1 μg DNA to 100 μl of Xfect buffer. This solution 
was incubated for 10 minutes, then added directly to cells. After 4 hours, cells were washed and the media 
replaced. For RNA Xfect transfections, 2 µg of RNA was diluted to a volume of 100 µl with Xfect 
reaction buffer. This was combined with a solution containing 10 µl of RNA transfection polymer and 
100 µl of Xfect reaction buffer. This solution was incubated for 10 minutes, then added directly to cells. 
After 4 hours, cells were washed and the media replaced. If greater amounts of RNA were transfected, 
the amount of polymer was increased proportionally. For combined Xfect transfections, 2 µg of RNA 
and up to 8 µg of DNA were diluted to a volume of 120 µl with Xfect reaction buffer. This was combined 
with a solution containing 0.3 µg of transfection polymer per µg of DNA diluted to 120 µl in Xfect 
reaction buffer and 10 µl of RNA transfection polymer. This solution was incubated for 10 minutes, then 
added directly to cells. After 4 hours, cells were washed and the media replaced. If DNA and RNA were 
transfected separately in the same dish, a 16-hour recovery buffer was given before the second 
transfection. After the final transfection, a 4-hour recovery period was given, at which point media was 
exchanged, either for media containing estradiol or DMSO vehicle. After 12-16 hours, cells were 
harvested for analysis. For protein expression analysis, cells were lysed using 0.1% SDS (Bio-Rad) with a 
protease inhibitor tablet (Roche) and vigorous pipetting, at which point they were run on a poly-
acrylamide gel (Bio-Rad, Any Kd gel). For luminescence analysis, cells were lysed using Cell Culture Lysis 
Reagent (Promega), which has been shown to be compatible with luminescence experiments. 
2.5.3 Protein Visualization 
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Cells were lysed in 0.1% SDS (Bio-Rad) containing a protease inhibitor pellet (Roche), with 200 µl 
used to harvest cells from a 35 mm plate. Lysate was mixed 3:1 with 4X SDS-loading buffer (100mM 
Tris, pH 6.8, 4% SDS, 0.2% bromophenol blue, 20 % glycerol, 200 mM DTT), then loaded onto 
polyacrylamide “Any Kd” gels (Bio-Rad). Unused lysate was flash frozen using liquid nitrogen and kept 
for additional experiments. Gels were run for ~50 minutes using SDS-running buffer (25 mM Tris, 192 
mM glycine, 0.1% SDS). At this point, proteins containing a fluorescent marker, such as eGFP-eEF1a, 
were visualized directly using the Typhoon (GE Healthcare). Although this method does not allow for 
quantitative analysis – since some percentage of the GFP chromophore will have bleached on the 
denaturing gels – it does provide an approximate comparison for conditions run on the same gel. To 
analyze proteins that did not contain fluorescent proteins, western blots were run. Completed gels were 
transferred to Immun-blot® LF PVDF (Bio-Rad) using a wet transfer technique. The PVDF was blocked 
for 1 hour using 5% evaporated milk (Carnation) in TPBS (10 mM Na3PO4, 150 mM NaCl, pH 7.8, .1% 
Tween), then incubated for 1 hour in 5% evaporated milk in TPBS with the appropriate antibody (all 
mouse derived, for use with goat anti-mouse secondary). Concentrations were adjusted to obtain 
reasonable signal relative to an anti-tubulin antibody. The membrane was washed 4 times with TPBS, 
incubated for another hour with 5% evaporated milk in TPBS with a 1:3000 dilution of goat anti-mouse 
680 antibody (Life Technologies), then washed 3 more times. Blots were visualized using the Odyssey 
imaging apparatus (Licor). 
2.5.4 Luminescence Assay Protocol 
 Luciferase assays were performed using the dual luciferase assay system or Renilla luciferase assay 
system depending on the experiment (Promega). Following transfection and treatment with either 
estradiol or vehicle, cells were lysed using the Cell Culture Lysis Reagent (Promega), which is compatible 
with all luciferase assays. Briefly, 300 µL of Cell Culture Lysis Reagent (Promega) was generated from a 
5X stock for each plate of cells to be lysed. This solution was then pipetted vigorously with cells. Once 
all cellular material was suspended, the solution was transferred to an Eppendorf tube and allowed to 
rock for 15 minutes at 4° C. This solution was then spun down at 10,000 g, and the supernatant used to 
  
46 
seed a luminescence assay. Specifically, 60 µl of the lysis solution was added to 300 µl of a luciferase assay 
reagent, either LAR II for the dual luciferase assay or Renilla Luciferase Assay Reagent for the Renilla 
luciferase assay (Promega). From this solution, three 100 µL aliquots were removed for analysis by a 96-
well plate luminescence assay using a Flexstation 3 (Molecular Devices). For the Renilla luciferase assay 
this was the end, but for the dual assay system, after assessing the firefly luciferase signal, Stop and Glo 
buffer (Promega) was added to quench the firefly luciferase signal and initiate the Renilla luciferase signal. 
The Renilla luciferase luminescence was then also recorded using a Flexstation 3 (Molecular Devices). For 
the dual assay system, the triplicates were averaged and standardized against the Renilla luciferase signal 
for a final luminescence value.  
2.5.5 Estrogen Receptor Recovery Experiments 
 HEK-293T cells were transfected as previously described with three plasmids: one containing an 
estrogen response element, one containing a Renilla luciferase, and one containing estrogen receptor, 
either the wild type or a mutant. tRNA was all transfected, usually at the same time, although temporally 
separated transfections were also evaluated. Estradiol was added between 8-12 hours after the start of 
transfection (to allow time for transfection and recovery) via a media exchange. Many concentrations of 
estradiol were initially tested, but ultimately all data was collected with 10 µM estradiol, a value that fell 
within the middle of the literature range.  After 12-16 hours of incubation in estradiol, transcriptional 
activation was evaluated by luciferase assay, with Renilla luciferase activity serving as a control for 
transfection efficiency, protein concentration, and machine variability. Although 12-16 hours is a 
somewhat quick turnaround time for protein expression, a number of different time points were tested, 
and significant differences in wild type signal were not observed in incubations ranging from 12-36 hours. 
Since chemically acylated tRNA is not expected to persist unused in the cellular environment, an earlier 
time point was ultimately selected to increase the concentration of noncanonical amino acid containing 
protein. Further time points were still tested with acylated tRNA, but a rigorous time course was not 
performed due to the value of acylated tRNA. 
2.5.6 Renilla Luciferase Recovery Experiments 
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 The Renilla luciferase recovery experiments were designed to simplify the overall recovery assay by 
reducing the number of required plasmids to one and eliminating steps in between noncanonical amino 
acid incorporation and observable chemiluminescence. Towards this end, a plasmid containing Renilla 
luciferase or a mutant Renilla luciferase was transfected along with tRNA. Although this tRNA was usually 
transfected along with the plasmid, temporally separated transfections were also evaluated. 12-16 hours 
after the transfection was completed, cells were harvested and a Renilla luciferase assay was run. In these 
experiments, there was no control luciferase, but the decreased complexity of the transfection suggested 
this was less of an issue. For EF1a upregulation experiments or BPNT1 downregulation experiments, 
two sequential transfections were run. In the first, the Renilla luciferase plasmid was transfected with 
either the EF1a plasmid or BPNT1 siRNA. After screening for concentration effects, 4µg of ER1a and 
50 pm of BPNT1 siRNA were determined to be the optimal amounts. Following this first transfection 
and an 8-12 hour recovery period, a second transfection was run to introduce tRNA. After another 12-
16 hours, protein was isolated for analysis by gel electrophoresis or for luminescence experiments. 
2.5.7 Synthetase Control Experiment 
 To ensure that the selected TAG sites could indeed withstand mutant incorporation, a plasmid 
containing the F6TAG mutant of Renilla luciferase was transfected along with PU6 plasmids from the 
Krogsgaard lab containing a tRNA/synthetase pair for para-azidophenylalanine. These two plasmids 
were transfected at a ratio of 6 µg to 2 µg (respectively) following the previously outlined transfection 
protocols.  Cells were subsequently incubated in media containing 0.5 mM N3Phe for 24 hours prior to 
lysis, and the luminescence determined.  
2.5.8 Molecular Biology 
 Mutations were made using the QuickChange method (Stratagene) and DNA isolated using Qiagen 
mini prep or maxi prep kits. Chemically acylated tRNA was generated as previously described.14,22 74mer 
and 76mer tRNA were generated using the Ambion T7MEGAshortscript kit by transcription from a 
DNA oligonucleotide template modified to enhance RNA transcript homogeneity, as described in the 
literature.23 Crude tRNA-amino acid or tRNA-hydroxy acid product was used without desalting, and the 
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product was confirmed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry 
on a 3-hydroxypicolinic acid matrix. Deprotection of the NVOC group on the tRNA-amino acids was 
carried out by photolysis for 5 minutes on a 300-watt high-pressure mercury arc lamp with WG-335 and 
UG-11 filters. This was done immediately prior to transfection.  
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Chapter 3: Exploration of Singlet Oxygen-Mediated Upconversion as an Upconversion 
Phenomenon with Potential Applications in Biological Systems 
 
3.1 Abstract 
 In recent years, significant interest has arisen in understanding complex photophysical phenomena 
and exploiting them for a variety of biological and chemical purposes. Singlet fission, triplet-triplet 
annihilation, and delayed fluorescence are all actively being adapted into practical applications. One 
photophysical phenomenon that has yet to be fully explored is singlet oxygen-mediated upconversion 
(SOMUC). A complex interplay of energy transfer events that ultimately produces an excited state singlet, 
SOMUC occurs when a ground state dye interacts with singlet oxygen and is subsequently excited to the 
triplet state. This triplet state dye subsequently interacts with a second molecule of singlet oxygen and 
undergoes a second energy transfer event to reach the singlet excited state. From this point, the molecule 
behaves as a directly excited molecule would. If a dye is capable of generating singlet oxygen itself, this 
process can occur long after an initial excitation event, giving delayed fluorescence.  Unfortunately, due 
to the small number of dyes that undergo SOMUC and the lack of a defined application, research in the 
area has been slow. Still, recent interest in novel imaging techniques involving singlet oxygen, such as 
singlet oxygen triplet energy transfer, suggest that biological applications may exist for SOMUC. A better 
understanding of the photophysics involved in the process would help determine whether this was true. 
Described herein are attempts to better described the process of SOMUC in water using a robust singlet 
oxygen generator, Rose Bengal, and a SOMUC acceptor, AlPcS4. 
 3.2 Introduction 
3.2.1 Photophysics of Singlet Oxygen-Mediated Upconversion  
 Complex photophysical phenomena in dyes are being investigated with increasing intensity as their 
utility is becoming more apparent. Although a number of processes have been described, singlet fission, 
triplet-triplet annihilation, and delayed fluorescence are the most prominent among them, particularly in 
terms of practical applications. Singlet fission is being used to develop novel solar materials, triplet-triplet 
annihilation is being used as the basis for dye-sensitized solar cells, and delayed fluorescence is being used 
for organic light emitting diodes. 1–4 All three processes have been integral in redefining the use of light 
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in day-to-day chemistry. Although they seem complex, these processes are ultimately relatively 
straightforward events in the context of a Jablonski diagram. In singlet fission, one excited state singlet 
chromophore interacts with a neighboring ground state chromophore to generate two excited state triplet 
chromophores, providing a greater number of excited state species at lower energies (Figure 1A). Due to 
the short lifetime of the singlet state, this is usually an intramolecular event. In triplet-triplet annihilation, 
two excited state triplet chromophores interact to produce one excited state singlet chromophore and 
one ground state chromophore (Figure 1B). This can be intramolecular or intermolecular, as the triplet 
state is much longer lived than the singlet state. In delayed fluorescence, a molecule that has relaxed into 
a lower energy excited state is returned to an emissive excited state allowing it to fluoresce (Figure 1C). 
This can occur via a number of ways, but one of the most common is through thermal excitation. 
 A photophysical process that has received significantly less attention than the three denoted is singlet 
oxygen-mediated upconversion (SOMUC). In this process a chromophore is excited from the ground 
state to the triplet state by interacting with 
an excited state oxygen molecule known 
as singlet oxygen (Figure 2).5 Following 
this initial energy transfer, the now triplet 
state chromophore interacts with a 
second molecule of singlet oxygen, 
initiating a second energy transfer and 
producing an excited state singlet 
chromophore. A variation on this process 
exists where two chromophores are first 
excited to the triplet state via singlet 
oxygen, then interact with each other via Figure 1: Energy level diagrams for common photophysical 
processes. A.)  Singlet fission. B.) Triplet-triplet annihilation. C.) 
Delayed fluorescence (thermally activated in this case).  
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triplet-triplet annihilation to generate a 
singlet excited state chromophore and a 
ground state chromophore.  As described 
so far, SOMUC requires both a sensitizer 
capable of generating singlet oxygen and 
a chromophore capable of using the 
energy; however, in a number of systems 
explored, the same dye serves both roles.   
  There are three reasons why SOMUC 
has not yet been explored in depth. The 
first is that the process is fairly complex. 
Singlet fission, triplet-triplet annihilation, 
and delayed fluorescence all required a 
single step after excitation to obtain the final excited state, whereas SOMUC is a multistep process. The 
second is that few dyes are capable of accepting energy from singlet oxygen, which has hampered 
attempts to develop SOMUC systems. The third is that few practical applications for SOMUC have been 
shown to date. Although NIR upconversion has been demonstrated using the method, the low quantum 
yields obtained were far from compelling.5 Despite these limitations, SOMUC is still being studied, albeit 
at a much slower pace than previously mentioned biophysical processes.  
 A version of SOMUC that leads to fluorescence, known as singlet oxygen-sensitized delayed 
fluorescence (SOSDF), was first demonstrated in 1968 using the chromophore violanthrone.6 When 
exposed to chemically generated singlet oxygen, the chromophore was shown to glow red, suggesting 
excitation of the dye was occurring via an energy transfer process. Over the years, similar processes were 
observed in the context of chemically generated singlet oxygen, thermally generated singlet oxygen, and 
photochemically generated singlet oxygen, supporting the notion that singlet oxygen was capable of 
Figure 2: Singlet Oxygen-Mediated Upconversion. The S 
stands for sensitizer and the E for emitter. Adapted from Fückel 
et al.5 
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exciting certain chromophores 
from the ground state to the 
excited state via energy transfer 
processes.7–10 Most recent 
among these studies was an 
investigation into different 
chromophores and their SOSDF 
in the context of an aqueous 
environment.10 This study 
analyzed the ability of six 
common water soluble photosensitizers (AlPcS4, TPPS4, TMPyP, Methylene Blue, Rose Bengal, and 
Eosin Y) to mediate singlet oxygen-sensitized delayed fluorescence.10 All of the dyes except methylene 
blue were capable of producing a delayed fluorescence response, although Eosin Y and AlPcS4 did so the 
most robustly (Figure 3).10 To ensure that this fluorescence was a consequence of singlet oxygen 
generation, a number of controls were run. First, the excitations and observation were carried out in the 
presence of NaN3, a known singlet oxygen quencher. The presence of azide significantly inhibited delayed 
fluorescence, suggesting that the effect was oxygen mediated.10 To provide further proof, SOSDF 
experiments were next run in deuterated solvent. Since solvent deuteration increases the lifetime of singlet 
oxygen, it was expected that the lifetime of the delayed fluorescence would also increase if the delayed 
fluorescence was singlet oxygen dependent. An increased fluorescence lifetime was observed in D2O, 
corroborating the azide results.10 Finally, the intensity of SOSDF was evaluated as a function of the 
concentration of oxygen in solution. Interestingly, a parabolic curve was observed, suggesting that 
SOSDF was indeed dependent on the concentration of oxygen, but that the mechanism was fairly 
complex.10 In total, these results demonstrated that a number of common photosensitizers were capable 
of SOSDF. 
3.2.2 Singlet Oxygen in Biology   
Figure 3: Singlet oxygen-sensitized delayed fluorescence with 
common water soluble photosensitizers. A trace including NaN3 (as 
singlet oxygen quencher) is included as a control. Adapted from Scholz 
et al.10 
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 In addition to verifying the oxygen dependent nature of SOSDF in select water soluble 
photosensitizers, the authors examined SOSDF in the context of mammalian cells, specifically 3T3 
mouse fibroblasts.10 They determined that SOSDF was possible in cells using a suspension of 
fibroblasts10, a result that was later corroborated in adherent cells.11 Although this observation itself is of 
little practical use, it is interesting in the context of other singlet oxygen based phenomena. Specifically, 
singlet oxygen has previously been used to characterize protein-protein interactions through a method 
known as singlet oxygen triplet energy transfer (STET). Although this method is incredibly robust for 
evaluating long range protein-protein interactions, it cannot provide temporal information. The ability to 
evaluate protein-protein interactions in real time through a singlet oxygen mediated event would provide 
a significant breakthrough in understanding long range protein-protein interactions, and the fact that 
SOSDF occurs in cells suggests that SOSDF may be able provide the temporal component absent in 
STET.  
 STET is a process by which the spatial relationship of a singlet oxygen generator and a singlet oxygen 
sensor are determined based on quenching of the singlet oxygen sensor by the singlet oxygen generator 
(Figure 4).12 This method can conceptually be compared to FRET, where an energy transfer event 
produces either quenching or excitation, however, it is an irreversible process, as the quenching is 
chemical in nature and can occur only once. The value of STET is that it can evaluate long range protein-
protein interactions due the distance singlet oxygen can 
travel in its lifetime.12 Its limitation is that is has no 
temporal resolution; once the singlet oxygen sensor is 
quenched, no additional observations can be made.12 A 
process in which an event mediated by singlet oxygen 
was reversible would overcome the limitations 
inherent to STET. Although chemical quenching 
events are either too destructive or too slow to be 
considered reversible in the context of a cell, it is 
Figure 4: Schematic of STET. Both the 
biological and photophysical principles are 
shown. Adapted from To et al.11 
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possible that a photophysical event, such as SOSDF, would provide a reversible, observable readout. 
Before exploring the potential biological applications of SOSDF, however, a greater photophysical 
description of the process is required. 
3.3 Results and Discussion 
3.3.1 Development of an SOSDF Assay 
 To determine whether or not SOSDF could be of practical use in a biological system, a better 
understanding of the underlying photophysical processes was pursued. Because a novel data collection 
setup had to be developed, the first attempts at using singlet oxygen-mediated upconversion were focused 
on recapitulating data previously obtained with a robust SOSDF system.9 Specifically, an upconversion-
capable phthalocyanine known as tBPc and the singlet oxygen sensitizer C60 were irradiated in C6D6.9 
tBPc was selected for its high SOMUC efficiency and solubility in nonpolar solvents, C60 was chosen 
for its high singlet oxygen yields and low fluorescence background, and C6D6 was chosen for the 
extremely long lifetime of singlet oxygen in the solvent. In combination, the system produced delayed 
fluorescence that lasted hundreds of 
microseconds.9 Working with 
Oliver Shafaat on developing a data 
collection setup, we were capable of 
reproducing previously observed 
data (Figure 5). Importantly, upon 
freeze-pump-thawing samples (a 
process that removes most oxygen), 
no delayed fluorescence was 
observed, demonstrating that the 
observed process was indeed a 
singlet oxygen mediated event. 
Figure 5: SOMUC of tBPc in C6D6 via excitation of C60. C60 was 
excited at 532 nm. Extreme signal decrease is seen upon FPT, 
demonstrating that the process is singlet oxygen dependent. The X-
axis is time in seconds and Y-axis is relative intensity. 
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 Following the success of this initial event, the setup was refined to allow analysis of systems with 
much shorter lifetimes in D2O (Figure 6). To simplify initial attempts with this setup, SOSDF was 
attempted with a single chromophore, AlPcS4, rather than with a two component system. Capturing these 
data proved significantly more difficult, as the shortened fluorescence life time in D2O led to significant 
overlap between prompt fluorescence and delayed fluorescence. This prompt fluorescence would 
overload the image intensifier, making it impossible to capture the subtleties associated with delayed 
fluorescence. To overcome this issue, we instituted a trigger that offset photon collection by 100s of 
nanoseconds from the initial irradiation event. This allowed a majority of the prompt fluorescence to 
cease prior to collection, which resulted in much cleaner delayed fluorescence spectra. Using a 625 nm 
excitation laser, a delayed fluorescence lifetime was obtained that was comparable to that previously 
reported.10 As in the initial experiments, a freeze-pump-thawed (FPT) sample was compared to an 
atmospheric sample to determine the effect of oxygen on the AlPcS4 delayed fluorescence spectra. 
Interestingly, signal was observed for both the FPT and the atmospheric sample, but the traces were very 
different. The FPT sample gave a long, slow decline, suggestive of phosphorescence, whereas the 
atmospheric sample gave a sharp curve comparable to previous SOSDF data (Figure 7). Either way, these 
data demonstrated that delayed emissions for AlPcS4 could be visualized using our setup, and that more 
complicated experiments could be run. 
3.3.2 Exploration of Factors Affecting SOSDF Signal Intensity and Duration  
Figure 6: Simplified setup for the collection of SOSDF data. Laser excitation of an SOSDF solution 
produces prompt fluorescence, which is not collected by the image intensifier, as it is not on. After 
hundreds of nanoseconds, the image intensifier turns on and begins collecting emission data, however, at 
this point all light collected is either phosphorescence or delayed fluorescence. Due to the low intensity of 
delayed fluorescence, significant surface area on the image intensifier is required to get enough signal. 
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 Having determined a suitable setup for 
measuring delayed fluorescence, the SOSDF 
intensity was evaluated at varying concentrations of 
AlPcS4 (Figure 8). As expected, an approximately 
linear trend was observed for intensity as a function 
of concentration. Interestingly, the fluorescence 
lifetime also shifted a small amount as a function of 
AlPcS4 concentration, but never significantly enough 
to suggest that it would be a variable worth 
monitoring in the context of a biological application. 
The consistent results obtained with AlPcS4 
prompted exploration of two component SOSDF 
systems.  
 Three dyes were initially considered to 
complement AlPcS4: Eosin Y, TMPyP, and Rose 
Bengal. Eosin Y was explored first due to its 
synthetic utility, however, it produced too low of a 
signal to be used. TMPyP was explored next due to 
its desirable photophysical properties. Unfortunately, it formed a ground-state complex with AlPcS4 (as 
seen by UV-Vis), making it impossible to generate singlet oxygen. Rose Bengal was explored last. Even 
though it has favorable photophysical properties and water solubility, its emission profile overlaps with 
the absorption profile of AlPcS4, and therefore was avoided on the off chance that it participated in other 
photophysical processes such as FRET. Despite this initial concern, Rose Bengal produced the best two 
component SOSDF signal with AlPcS4 and was selected for use in all future studies (Figure 9). This initial 
excitation and all subsequent excitations utilizing Rose Bengal were carried out at a 532 nm excitation 
wavelength. 
Figure 8: AlPcS4 SOSDF as function of 
concentration. The X-axis is time in seconds and 
Y-axis is relative intensity.  
Figure 7: Delayed emission spectra of AlPcS4.  
Shown are atmospheric and FPT samples. The X-
axis is time in seconds and Y-axis is relative 
intensity. 
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 Before proceeding with further 
SOSDF experiments, three 
concerns were addressed. The first 
was the fact that in all previous 
setups, a small amount of 
background signal existed 
regardless of the conditions used. 
To explore lower concentration 
SOSDF solutions, this background 
needed to be eliminated 
completely, so the optical setup was 
optimized with blackout curtains to 
ensure no extraneous light entered. 
This ultimately had a large effect, 
reducing the background noise to 
negligible levels for subsequent 
experiments. The second was that 
Rose Bengal and AlPcS4 could 
possibly FRET and obscure the 
SOSDF results in the process. To determine whether or not this was an issue, picosecond absorption 
spectroscopy was done to evaluate the lifetime of the Rose Bengal excited state as a function of the 
AlPcS4 concentration (Figure 10). A lifetime of approximately 100 picoseconds was observed for all 
concentrations of AlPcS4, demonstrating that FRET was not a significant phenomenon, even at high 
levels of AlPcS4 and suggesting that the duo was worth using for continued SOSDF experiments. The 
final concern addressed was whether or not AlPcS4 would undergo SOSDF upon excitation at 532 nm. 
Although AlPcS4 does not have significant absorbance in this area, any autonomous SOSDF would have 
Figure 9: RB-AlPcS4 SOSDF. Rose Bengal and AlPcS4 are shown 
above the spectra. The complete excitation system is shown in blue, 
whereas all other colors represent controls. Notably, a small amount 
of background signal exists regardless of the solution, suggesting 
some inherent noise in the imaging conditions.  The X-axis is time 
in seconds and Y-axis is relative intensity.   
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an effect on the final results and should be 
considered. Surprisingly, a small amount of 
delayed fluorescence was observed when 
irradiating AlPcS4 at 532 nm (Figure 11). 
The results were inconsistent (even when 
irradiating at similar concentrations), but in 
all cases the observed lifetimes were 
significantly less than those associated with 
the Rose Bengal-AlPcS4 combination. 
Although this result was slightly 
disheartening, the small magnitude of the emission suggested that it would not significantly affect 
interpretation of the combination SOSDF data.  
Having addressed the three concerns associated with the SOSDF setup and chromophore 
combination, a series of experiments was run to understand the effects of concentration on the two 
component system. Starting by keeping the Rose Bengal concentration constant at 10 µM, the 
concentration of AlPcS4 was varied (Figure 12). Unfortunately, the precautions taken to limit the amount 
of background signal significantly reduced 
overall signal, resulting in noisier spectra. 
That being said, the spectra were still 
interpretable. Interestingly, the concentration 
of AlPcS4 seemed to have little effect on 
either the lifetime or intensity produced by 
the SOSDF. An increase in the AlPcS4 
concentration should mean that more singlet 
oxygen is being funneled into ground state 
AlPcS4 rather than the AlPcS4 excited state 
Figure 11: AlPCs4 SOSDF at 532 nm. The X-axis is time 
in nanoseconds and Y-axis is relative intensity.   
Figure 10: Rose Bengal lifetime as a function of AlPcS4 
concentration. The X-axis is time in nanoseconds and Y-axis 
is relative intensity.   
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triplet, failing to produce delayed 
fluorescence. However, these data 
demonstrate that the end result of 
excitation is similar regardless. This 
suggests that the generated AlPcS4 triplet 
state is still productive in the context of 
SOSDF, either undergoing triplet-triplet 
annihilation to generate singlet excited 
states or relaxing via sensitization of 
oxygen and reinitiating the process. Next, 
the concentration of Rose Bengal –  and 
consequently singlet oxygen – was varied while the concentration of AlPcS4 was kept constant at 10 µM 
(Figure 13). This had a significantly larger effect on the signal intensity, as well as on the lifetime. Although 
the signal intensity increased approximately linearly as a function of Rose Bengal concentration, the 
lifetime decreased slightly as the Rose Bengal concentration increased. This is a somewhat surprising 
result, but the effect was not large enough to warrant a more in depth evaluation. As mentioned 
previously, some inherent SOSDF is 
observed when AlPcS4 is irradiated at 532 
nm. Although a factor of ten difference in 
lifetime exists between AlPcS4 SOSDF and 
dual chromophore SOSDF at this 
wavelength, to understand this result more 
qualitatively, traces from both systems were 
normalized and compared. Reassuringly, 
the two decay patterns differ significantly 
(Figure 14). Although autonomous SOSDF 
Figure 12: RB-AlPcS4 SOSDF as a function of AlPcS4 
concentration. The X-axis is time in seconds and Y-axis is 
relative intensity.   
Figure 13: AlPcS4-RB SOSDF as a function of RB 
concentration. The X-axis is time in seconds and Y-axis is 
relative intensity.   
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is unavoidable in this system, it 
seems as though it does not obscure 
the dual chromophore SOSDF 
results. 
Having determined the 
concentration effects of the two 
partners, the sensitivity of the 
process to singlet oxygen was next 
evaluated. First, a FPT irradiation 
containing 100 µM of both 
chromophores was run and compared to an atmospheric sample. As expected, no significant delayed 
fluorescence was observed (Figure 15). Since quenching with azide had already been demonstrated in 
earlier SOSDF combo experiments, solvent effects were next evaluated.   
As expected, irradiation in H2O gave significantly different lifetimes than irradiation in D2O (Figure 
16). Interestingly, the lifetime difference – a factor of 10 – tracks well with the difference in singlet oxygen 
lifetimes in the two solvents. Having extensively demonstrated the dependence of the delayed 
fluorescence on oxygen, the next step was to evaluate the phenomenon in a more biological setting.  
To approximate a more biological setting, 
SOSDF experiments were next run in cell 
lysate. Starting with a low concentration of cell 
lysate (10 %) mixed with either H2O and D2O, 
lifetimes were observed that were similar to 
samples containing no cell lysate (Figure 17). 
Interestingly, although the lifetime did not 
change significantly, a decrease in SOSDF Figure 15: AlPcS4 SOSDF under atmospheric and 
FPT conditions. The X-axis is time in seconds and Y-
axis is relative intensity.   
Figure 14: Comparison of AlPcS4 SOSDF (denoted phth) and 
AlPcS4-RB SOSDF. The X-axis is time in seconds and Y-axis is 
relative intensity.   
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intensity was noticeable, suggesting that 
fluorescence is either being absorbed or 
scattered by the lysate. Upon increasing the 
concentration of lysate to 55%, a shift in 
lifetime was observed in the case of the 
D2O sample. Given that the lysate is in 
H2O, it is somewhat difficult to determine 
whether or not the effect is a consequence 
of the biological environment or the H2O. 
Regardless, the H2O sample did not shift 
significantly, suggesting that at the very 
least the described dual chromophore 
SOSDF could work in a biological system. 
 At this point, the Rose Bengal-AlPcS4 
combination had been thoroughly vetted, 
however, before moving into a more 
complicated system, I wanted to find a set 
of dyes capable of singlet oxygen-mediated 
upconversion. By using singlet oxygen to 
upconvert a long wavelength excitation to a shorter wavelength emission, ambiguities associated with 
AlPcS4 self-excitation would be cleaned up and ultimately a more robust SOSDF system would be 
developed. Furthermore, upconversion is itself of practical importance. No dye like this existed, so I set 
out to synthesize one. Unfortunately, my Ph.D. completed before I was capable of revisiting this topic 
with a novel set of dyes. 
3.4 Conclusion 
Figure 16: Effects of solvent deuteration on SOSDF. The 
X-axis is time in seconds and Y-axis is relative intensity.   
Figure 17: SOSDF in the presence of 10% cell lysate. The 
X-axis is time in seconds and Y-axis is relative intensity.   
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 Singlet oxygen sensitized delayed fluorescence is an unexplored photophysical phenomenon. 
Described herein were efforts to better describe SOSDF in the context of an aqueous, dual chromophore 
system. Results demonstrated the importance of individual components, and suggested that the obtained 
signal was sensitive to both the environment and the concentration of singlet oxygen, facts that could 
potentially be exploited for biological imaging. Further exploration of SOSDF is warranted, both in the 
context of the described Rose Bengal-AlPcS4 system and in the context of upconversion. 
3.5 Materials and Methods 
3.5.1 Materials 
 AlPcS4 was obtained from Frontier Scientific. Rose Bengal, Eosin Y, and TMPyP were obtained from 
Sigma-Aldrich. Deuterated solvents were obtained from Cambridge Isotope Laboratories. Quartz 
cuvettes were obtained from Starna Cells, and FPT capable quartz cuvettes were generated in the glass 
shop at Caltech.  
3.5.2 Irradiation Experiments 
 Irradiation experiments were carried out on laser tables in Caltech’s Beckman Institute Laser Resource 
Center with the help of Oliver Shafaat and Jay Winkler. Two different lasers were used depending on the 
application. A nanosecond laser was used for all SOSDF experiments, and a picosecond laser was used 
for all FRET experiments with Rose Bengal. The nanosecond laser used was a Spectrophysics Quanta 
Ray Nd:YAG  OPO system capable of producing a range of visible wavelengths for irradiation. Data 
from Nd:YAG irradiations were collected via an Oriel Image Intensifier, which was set to activate after 
the end of the irradiation pulse. All setup was monitored using a Teledyne Lecroy Wavejet Touch 364 
oscilloscope. The picosecond laser setup was devised by Jay Winkler, and also utilizes an Nd:YAG laser 
source. Data collection for the FRET experiments was performed using a Hamamatsu 
spectrophotometer. All irradiations were performed using quartz cuvettes with a 1 cm path length and 
stirring solutions.  
3.5.3 Freeze-Pump-Thaw Protocol 
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 Using a specially designed quartz cuvette, solvent was frozen under atmospheric conditions in an 
attached glass bulb. A vacuum was then applied to remove all gas, and the solvent allowed to thaw under 
the degassed conditions. This allowed dissolved gas to escape into the headspace. The process was 
repeated twice more without exposing the system to the atmosphere. After the final cycle of thawing, the 
sample was placed under argon and transferred from the glass bulb to the quartz cuvette for irradiation. 
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Chapter 4: Exploration of Phenothiazine Derivatives as Singlet Oxygen-Mediated 
Photoremovable Protecting Groups 
 
4.1 Abstract 
 Recent work by Schnermann and coworkers has demonstrated the potential of singlet oxygen-
mediated photodeprotection. Their work was inspired by the oxidative instability of cyanine dyes, which 
collapse upon interaction with singlet oxygen. By joining a cyanine dye to an appropriate leaving group, 
the method was used to liberate both alcohols and amines. Despite the success of these cyanine dye 
protecting groups, this design principle has yet to be expanded to other systems.  This is surprising, as 
the potential of this breakthrough is significant; the photochemical generation of singlet oxygen has been 
demonstrated at much longer wavelengths than has direct photochemical deprotection, providing an 
opportunity for long wavelength photodeprotection. Further expansion of the methodology could be 
pursued via a number of avenues, however, of particular interest are scaffolds based on a phenothiazine 
backbone. The phenothiazine backbone is particularly promising due to the high singlet oxygen quantum 
yields and synthetic modularity that are associated with it. Described herein are initial attempts to generate 
scaffolds capable of singlet oxygen-mediated photorelease based on a phenothiazine backbone. Different 
phenothiazine derivatives are explored, as are different cages that collapse in the presence of singlet 
oxygen. Here I describe progress in the realm of singlet oxygen mediated photorelease. 
4.2 Introduction 
4.2.1 Photoremovable Protecting Groups and Singlet Oxygen-Mediated Deprotection 
 Protecting groups are integral in both chemistry and biology. In chemistry, they help define reactivity 
and selectivity, affording new approaches for complex syntheses. In biology, they allow for the regulation 
of complex networks. Although the protecting groups used in the two disciplines vary drastically, they 
tend to overlap in the context of photochemistry. Photoremovable protecting groups have been shown 
to be immensely impactful in chemical biology since the first reports of photochemically caged cAMP 
and ATP were published approximately 50 years ago.1,2 
 Over the past 50 years, photochemists have primarily focused on trying to push the speed, selectivity, 
and applicability of photochemical processes, irrespective of the wavelength they utilize.3 Recently, 
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however, an interest in in vivo biological applications for photoremovable protecting groups has brought 
to light the need for photochemical reactions that occur at longer wavelengths, where greater tissue 
penetration is obtained and less biological damage is incurred.3 Significant progress has been made in this 
area – as a number of new reactions have been developed that utilize visible light – however, there is still 
much room for improvement.4–9  
 In the context of visible light mediated photodeprotection, three strategies have primarily been used. 
The first is direct deprotection via the excited state. Although this is challenging, exciting work is being 
done in this field, particularly with BODIPY dyes.5,6,10 The second is deprotection mediated through 
secondary thermal events. Recently, our group has had success in this area, developing a quinone 
trimethyl lock photocage.7 The third – a novel strategy that has been employed relatively recently – is the 
use of singlet oxygen to mediate oxidative events that lead to deprotection. This method has been met 
with significant excitement over the past few years9,11, however, the breadth of this strategy has yet to be 
explored. Of these three strategies, the third is most applicable to long wavelength photochemistry; dyes 
(such as indocyanine green) are known that absorb above 800 nm and generate singlet oxygen.12 
 Schnermann and coworkers demonstrated that 
irradiation of cyanine dyes leads to the formation 
of singlet oxygen which adds to the conjugated 
backbone (Figure 1).9 Following addition of 
singlet oxygen, subsequent collapse of the 
backbone occurs, which leaves behind an 
unstable intermediate. Further collapse of this 
intermediate can be coupled to ejection of a 
protecting group that will cyclize and release a 
free product. This process can be initiated across 
a range of cyanine dyes9,11,13,14, and can be 
modified to release amines. Despite the promise 
Figure 1: Proposed mechanism for cyanine 
photodeprotection mediated by singlet oxygen. 
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of this system, it suffers from a number of flaws. The first is the speed. The process is inherently slow, 
due to both low singlet oxygen quantum yields inherent to cyanine dyes and subsequent dark steps that 
occur slowly. This inhibits its utility in dynamic systems – initial experiments required a 30-minute 
irradiation followed by a four-hour incubation at 37°C to achieve 60% photorelease.13 The second is the 
toxicity of the byproducts. Many of the cyanine dye decomposition byproducts are suspected to be toxic, 
limiting the use of the cage in biological systems. The final flaw is the substrate scope. Although recent 
papers have attempted to address this issue, the scope is still somewhat limited.9,11,14 
4.2.2 New Approaches for Singlet Oxygen-Mediated Deprotection 
 To improve upon the concept of singlet oxygen mediated photorelease, a potent singlet oxygen 
generator must be combined with a singlet oxygen sensitive cage that is rapid and robust. For biological 
purposes the entire construct should be water soluble, suggesting an ideal starting point would be water 
soluble dyes. Although a number of water soluble dyes are known that generate singlet oxygen, 
phenothiazine dyes are particularly attractive, as they are synthetically accessible and can be modified for 
subsequent use. The most well-known phenothiazine dye is methylene blue (Figure 2A), which has found 
a number of uses in chemistry and biology. It is perhaps best known for its place on the World Health 
Organization’s List of Essential Medicines – as it is used to treat methemoglobinemia – however, from a 
photochemist’s perspective it is a robust singlet oxygen generator, with a quantum yield of 39%.15 
Notably, methylene blue derivatives have been described in which the amino methyl groups are replaced 
with more complex alkyl groups (Figure 2B), providing a starting point for subsequent modification with 
singlet oxygen sensitive cages.16 Beyond methylene blue, some longer wavelength phenothiazine 
derivatives capable of generating singlet oxygen have been described, suggesting that singlet oxygen-
mediated photodeprotection could be performed at wavelengths above 900 nm (Figure 2C).17,18 
 Although different singlet oxygen sensitive moieties have been described, two in particular standout. 
The first is an alkene dithioether comprised of two thioethers bridged by an alkene (Figure 3A). Collapse 
of this group is initiated by the addition of singlet oxygen across the double bond, leading to formation 
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of a dioxetane. This dioxetane subsequently collapses to release thioesters, separating the previously 
linked components. This process is well characterized, and has been utilized in a number of applications 
where physical release is more important than the chemical context.19,20 This cage is not without its flaws 
– mainly lower yields due to thioether oxidation and a thioester scar that is appended to the leaving group 
– however, it is fairly robust and is a good starting point for initial explorations into singlet oxygen 
mediated photorelease. The second singlet oxygen sensitive moiety to consider is anthracene. Singlet 
oxygen is known to readily add across anthracene, which is actually the basis for a number of singlet 
oxygen detectors, such as singlet oxygen sensor green.21 Although this addition leads to no additional 
chemistry in the parent anthracene, in 9,10-dialkoxyanthracene derivatives (Figure 3B), the bridged 
oxygen will collapse following addition, leading to the formation of anthraquinone and the release of the 
alkoxy groups.22 This process has only been demonstrated using alcohols, however, it stands to reason 
Figure 2: Methylene Blue and associated phenothiazine derivatives. A.) Structure of methylene blue. B.) 
Structure of select methylene blue derivatives characterized by Gollmer et al.16 C.) Structure of NIR-
phenothiazine derivative characterized by Hsieh et al.18 
Figure 3: Singlet oxygen-mediated photorelease. A.) Alkene dithioether singlet oxygen-mediated 
photorelease. B.) Dialkoxyanthracene singlet oxygen mediated photorelease. 
A 
B 
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that similar reactivity would be obtained from anthracenes derivatized with amines and thiols, both of 
which are synthetically acessible.23,24 
4.3 Results and Discussion   
4.3.1 Exploration of Phenothiazine Derivatives as Singlet Oxygen Generators 
 To explore the possibility of singlet oxygen mediated-deprotection in the context of phenothiazines, 
derivatives were synthesized and evaluated for their ability to generate singlet oxygen. The first 
phenothiazine derivatives explored were based on a previously described long-wavelength phenothiazine 
derivative, o-DAP (Figure 2C). This dye has a λmax of 957 nm, and was shown to decrease the signal 
associated with a singlet oxygen sensor – 1,3-diphenylisobenzofuran (DPBF) – upon irradiation with a 
broad spectrum NIR light (700-1000nm), which suggests that the dye can form singlet oxygen.18 Despite 
the lack of a few notable controls, these results suggested that o-DAP was worth exploring further. 
Although the literature provided a synthetic route that purported reasonable yields, it was found that the 
described synthesis was difficult to recapitulate, particularly due to side product formation via cross-
coupling to the amine of dibromophenothiazine. An alternative path to the product was designed (Figure 
4), one that also afforded modification of the terminal anilines prior to the final deprotection and 
oxidation steps. Briefly, phenothiazine was brominated in the presence of bromine and acetic acid to 
produce dibromophenothiazine. This compound was subsequently subjected to protection via Boc 
anhydride, which gave protected product in good yield. Other protection strategies were explored, but 
were less robust. Next, a Suzuki coupling was used to couple the chromophore-extending aniline groups. 
Figure 4: Redesigned o-DAP synthesis. A new synthesis was designed to obtain a protected o-DAP precursor 
that could either be deprotected and oxidized to give o-DAP or modified prior to deprotection and oxidation 
give an o-DAP derivative. This synthesis was designed due to an inability to recapitulate a reported synthesis.  
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Due to the protection of the phenothiazine amine, this reaction proceeded efficiently, yielding a product 
that was ready for subsequent modification or deprotection/oxidation. Overall, the pathway to the 
protected product proved robust. More difficult, however, was determining conditions for subsequent 
deprotection and oxidation reactions.      
 Different deprotection conditions was explored, and ultimately 10% TFA in DCM was selected as 
the best deprotection condition. This left the product as a TFA salt, which could be quenched with 
saturated sodium bicarbonate and extracted into DCM. The obtained o-DAP precursor failed to exactly 
match the NMR spectra of the previously characterized o-DAP precursor despite having similar physical 
properties and the correct mass, suggesting that the deprotection left the dye in a slightly different state 
than the direct coupling. Subsequent oxidation of this dye with iodine led to a product with the UV-Vis 
(Figure 5) and mass spectra associated 
with o-DAP. However, an 
interpretable NMR could not be 
obtained, likely due to solubility 
issues. Different oxidation conditions 
were evaluated, however, iodine 
oxidation gave the best results.  
 Multiple attempts were made at producing singlet oxygen using a 940 nm LED and subsequently a 
980 nm laser, but, in comparison to a dark control no singlet oxygen generation was detected by DPBF 
degradation (Figure 6). In fact, the dark control suggested that the published DPBF signal decrease was 
a consequence of some process that was occurring in the dark. Additional singlet oxygen sensors, such 
as 9,10-anthracenediyl-bis(methylene)dimalonic acid (ABDA), were tested to no avail. Taken together, 
this suggested that reported singlet oxygen generation by o-DAP was not going to be recapitulated. 
However, before abandoning the dye completely, functionalization was explored to ensure that 
aggregation or solubility issues were not responsible for the observed results. Functionalization was 
initially attempted using the protected o-DAP precursor shown in Figure 6. Sulfonation was first evaluated 
Figure 5: o-DAP UV-Vis Spectrum. Taken in DMSO. 
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using 1,3-propanesultone. Although product formation could be observed by LC-MS, the reaction 
mixture was a complicated milieu involving multiple sulfonation products, making it nearly impossible to 
cleanly isolate a single one. To further complicate matters, Boc deprotection was observed as the reaction 
proceeded. To avoid the complicated product mixture produced by 1,3-propanesultone, alkylation with 
other groups was next explored. Although the ultimate goal was alkylation with masked solubilizing 
groups – such as esters that could be deprotected to form carboxylic acids – methylation was explored 
as a proof of principle. Attempts to methylate the o-DAP precursor directly proved unsuccessful, 
however, a methylated precursor could be used for the coupling reaction, giving clean product. Upon 
deprotection and oxidation, this precursor gave tetramethyl o-DAP, which could be characterized by mass 
spectrometry and NMR (Figure 7). Although tetramethyl o-DAP was not soluble in water, it was soluble 
Figure 7: Tetramethyl o-DAP synthesis. 
Pre-Irradiation 
Post-Irradiation 
Figure 6: Evaluation of o-DAP mediated singlet oxygen generation. Following irradiation with a 940 
nm LED over the course of an hour, no significant change in DPBF signal was observed despite a notable 
decrease in o-DAP absorbance. 
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in chloroform, and therefore was irradiated in CDCl3 in the presence of DPBF in an attempt to generate 
singlet oxygen. Unfortunately, no significant change in DPBF signal was observed when compared to a 
dark control. This once again suggested that o-DAP was incapable of generating singlet oxygen. However, 
this successful methylation opened the door to the possibility of alkylation with other groups and 
prompted attempts to generate a water soluble o-DAP.  
Alkylation of the protected o-DAP precursor with masked acetate groups was next evaluated using 
ethyl iodoacetate.  Although this alkylation was cleaner and more robust than the previous o-DAP 
methylation attempts, it was still difficult to obtain complete alkylation. The use of long reaction times 
helped. Other alkylating reagents were also explored, such as methyl bromoacetate, however, only ethyl 
iodoacetate gave complete alkylation. Isolation of the alkylated o-DAP proved challenging, but clean 
product was obtained and verified by NMR (Figure 8). Subsequent Boc deprotection and oxidation 
reactions gave a chloroform soluble product with a reasonably clean NMR. This product still failed to 
convincingly produce singlet oxygen, demonstrating a decrease in DPBF signal in CDCl3 in both an 
irradiated sample and a dark control. Despite this failure, one final attempt was made to generate water 
soluble o-DAP in hopes that some solvent effect was preventing singlet oxygen generation. 
Unfortunately, attempts to form carboxylic acids from the ester precursors were unsuccessful, generating 
a complicated mixture of products that could not be separated. In all, this suggested that o-DAP and its 
derivatives were not useful for generating singlet oxygen at near-infrared wavelengths. Before completely 
abandoning o-DAP as a singlet oxygen generator, a counterion exchange was attempted to ensure that 
the iodine counterion was not affecting the photochemistry. Exchange for tetrafluoroborate led to no 
change in the observed photochemistry.  
Figure 8: Alkylated o-DAP synthesis. 
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 Although the failure of o-DAP and its derivatives to 
produce singlet oxygen meant that long-wavelength 
photorelease was unlikely using phenothiazine derivatives, 
the accessibility of methylene blue derivatives suggested 
that singlet oxygen-mediated photorelease should still be explored in the context of visible light. Although 
a number of phenothiazine derivatives were prepared according to a literature procedure16, a piperazine 
derivative was of particular interest as it contained an additional amine for further functionalization 
(Figure 9). Singlet oxygen sensitive cages were next explored.   
4.3.2 Exploration of Singlet Oxygen Sensitive Cages 
 As mentioned previously, two singlet oxygen 
sensitive cages were considered. Initial efforts 
were focused on the alkene dithioether cage, 
specifically on functionalization of 1,2-dichloroethylene with alkane thiols, such as 2-mercaptoethanol 
(Figure 10). Ultimately these syntheses proved challenging, as complete separation of the alkane thiol 
precursor from the product was difficult to achieve. Although isolated cages could be cleaved in the 
presence of photochemically generated singlet oxygen, the process was far from robust, and focus was 
subsequently shifted to the development of anthracene photocages.   
 To explore anthracene photocages, an alcohol-
terminal 9,10-dialkoxyanthracene was first 
synthesized (Figure 11). Although this 
dialkoxyanthracene was not water soluble – and 
therefore not ideal for biological applications – it 
provided an opportunity to explore a previously 
described 9,10-dialkoxyanthracene synthesis. The synthesis proceeded as expected according to literature 
procedure, and the anthracene decomposed in the presence of photochemically generated singlet oxygen 
(as determined by HPLC). Anthraquinone was recovered following decomposition, demonstrating that 
Figure 10: 1,2-dichloroethylene functionalization 
with 2-mercaptoethanol. 
Figure 9: Piperazine methylene blue 
derivative for derivatization.  
Figure 11: 9,10-dialkoxyanthracene synthesis.  
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the photocage was working as previously described. These results suggested that heteroatom linked 
anthracenes were worth pursuing as singlet oxygen sensitive cages.  
To explore the scope of anthracene photocages, the singlet oxygen-mediated release of heteroatoms 
other than oxygen was next evaluated. The incorporation of both amines and thiols at the 9 and 10 
positions of anthracene has previously been described23,24, and initial synthetic attempts were based on 
literature precedent. Both dipropylamine and ethane thiol were successfully incorporated (Figure 12), 
generating a 9,10-diaminoanthracene and a 9,10-dithioanthracene respectively. To determine their 
sensitivity to singlet oxygen, each was combined with methylene blue and irradiated in methanol. Both 
anthracenes collapsed under these conditions and formed an identical product, ultimately identified to be 
anthraquinone (Figures 13 and 14). To ensure that this process was mediated by singlet oxygen, each 
sample was also irradiated after a freeze-pump-thaw procedure, which deoxygenated the solvent 
completely. The 9,10-dithioanthracene derivative was shown to be completely stable to irradiation of 
methylene blue under these conditions, suggesting that its decomposition was mediated solely by a path 
that required singlet oxygen formation. Interestingly, after freeze-pump-thawing, the 9,10-
diaminoanthracene was still susceptible to decomposition upon irradiation in the presence of methylene 
blue, albeit at a significantly slower rate. This suggested that degradation of the 9,10-diaminoanthracene 
occurred via multiple pathways, of which not all required singlet oxygen formation. This could be due to 
electron transfer events mediated by methylene blue, a process that has previously been observed in 
Figure 12: Synthesis of (A) diaminoanthracene and (B) dithioanthracene derivatives. 
A 
B 
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anilines.25 Regardless, the singlet oxygen mediated-pathway was still dominant in the 9,10-
diaminoanthracene, as evidenced by the observed rate difference following freeze-pump-thawing. Taken 
together, these results demonstrated that 9,10-anthracene heteroatom derivatives were susceptible to 
degradation in the presence of singlet oxygen, which suggested that a large breadth of molecules could 
be released by singlet oxygen using anthracene cages. 
Concurrent to explorations of heteroatom specificity, methods to increase the water solubility of 9,10-
dialkoxyanthracenes were being explored. Initial attempts focused on increasing the solubility of the 
Dark 
Atmospheric, 30 min Irr 
FPT, 2 Hour Irr 
Figure 14: 9,10-diaminoanthracene singlet oxygen sensitivity. Notably, degradation of the 9,10-
diaminoanthracene occurs in the absence of oxygen (the FPT sample) suggesting that an oxygen-free 
photochemistry is occurring, albeit at a slower rate. 
Dark Control 
Atmospheric, 30 Min Irr 
FPT, 1 Hour Irr 
Figure 13: 9,10-dithioanthracene singlet oxygen sensitivity. Notably, degradation of the 9,10-
dithioanthracene occurs only in the absence of oxygen.  
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caged group. The first route evaluated was selective oxidation of the terminal alcohols in 9,10-
dialkoxyanthracenebispropanol. Although this oxidation did produce some terminally oxidized product, 
it was part of a complex product mixture that was too difficult to separate. The next route explored was 
generation of 9,10-dialkoxyanthracenes with esters that could be cleaved to give carboxylic acids. 
Unfortunately, poor alkylation was observed, limiting progress along this synthetic route. Given the 
limited success of these attempts and the fact that the caged group itself is application dependent, 
subsequent attempts to increase solubility focused on modification of the anthracene cage. 
 2-chloroanthraquinone was chosen as a starting point for the development of more complex 
anthracene cages. Initial functionalization was attempted via condensation with piperazine, which gave 
2-piperazinylanthraquinone upon heating in ethanol. This new cage had significantly increased water 
solubility, and attempts were made to generate a new 9,10-dialkoxyanthracene from this scaffold. 
Unfortunately, subsequent attempts at reduction and alkylation were unsuccessful, likely due alkylation 
of the free amine. To avoid this side reaction, two avenues were explored. The first was to invert the 
order of modification, generating a 2-chloro-9,10-dialkoxyanthracene first and modifying it via 
condensation with piperazine second. Although a 2-chloro-9,10-dialkoxyanthracene was readily 
generated, it could not be subsequently modified to a 2-piperazinyl-9,10-dialkoxyanthracene. The second 
avenue explored was use of a protecting group to prevent the side reactivity associated with the 
piperazinyl amine. 1-Boc-piperazine was condensed onto 2-chloroanthraquinone, mimicking the 
piperazine condensation, however, this time the addition of a base (triethylamine) was required to give 
good yields. Subsequent alkylation to form a 9,10-dialkoxyanthracene was difficult to evaluate due to the 
insolubility of the product, but isolation of crude product and immediate Boc deprotection yielded a 
product that could be isolated. Although a combination of DCM/TFA gave better solubility for the crude 
Figure 15: 2-piperazinyl-9,10-dialkoxyanthracene synthesis. 
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deprotection, an aqueous solution containing methanol and HCl was ultimately used as it gave cleaner 
conversion to product (Figure 15). The isolated 2-piperazine-9,10-dialkoxyanthracene was soluble in 
water and sensitive to photochemical singlet oxygen generation (Figure 16). Notably, when running an 
irradiation experiment using a freeze-pump-thawed sample, starting material disappearance was still 
observed, suggesting that piperazinyl modification of the anthracene cage enabled an oxygen free 
degradation mechanism not seen in the parent 9,10-dialkoxyanthracene. Given that this compound 
contains a pendant amine, it is likely that this molecule and 9,10-diaminoanthracene collapse by the same 
mechanism in the absence of oxygen. 
4.3.3 Construction of a Scaffold for Singlet Oxygen Mediated Photorelease 
 Having demonstrated successful synthesis of a piperazinyl methylene blue derivative and 2-
piperazinyl-9,10-dialkoxy anthracene (Figure 17), the final step was to combine the two components to 
generate a complete scaffold for singlet oxygen-mediated photorelease. To start with the simplest system 
possible, the addition of 2-piperazinyl-anthraquinone to oxidized phenothiazine was attempted, similar 
to the reaction used to generate piperazinyl methylene blue. The addition of an array of secondary amines 
Dark Control 
Atmospheric, 1 Hour Irr  
FPT, 1 Hour Irr  
Figure 16: 2-piperazinyl-9,10-dialkoxyanthracene singlet oxygen sensitivity. Notably, 
degradation of the 2-piperazinyl-9,10-dialkoxyanthracene occurs in the absence of oxygen, 
suggesting that oxygen-free photochemistry is occurring, albeit at a slower rate. 
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to oxidized phenothiazine has been described in the 
literature16, although never in the context of an amine 
as complicated as 2-piperazinyl-anthraquinone. 
Unfortunately, this reaction was difficult to follow 
due to solubility issues, and never generated a 
significant amount of product. A comparable 
condensation with 2-piperazinyl-9,10-
dialkoxyanthracene was also unsuccessful. Coupling 
chemistry was explored next.  
Initial attempts to couple 2-piperazinyl-anthraquinone to Boc-dibromophenothiazine through 
Buchwald-Hartwig chemistry gave no product. To explore whether or not 2-piperazinyl-anthraquinone 
reactivity was in some way hampered due to steric constraints on the piperazine, 2-N,N’-
dimethylethylenediamine-anthraquinone was synthesized as a flexible analog. Although this molecule also 
exhibited limited reactivity, coupling conditions were ultimately determined that produced an 
anthraqunione-phenothiazine conjugate (Figure 18). Unfortunately, subsequent attempts at formation of 
a dialkoxyanthracene product in the context of this larger scaffold proved unsuccessful. Although the 
exact reason was unclear, mass spectrometry data suggested that some sort of cyclization was occurring, 
perhaps due to the flexibility associated with the N,N’-dimethylethylenediamine linker. To determine 
whether or not this was the case, coupling with 2-piperazinyl-anthraquinone was revisited in the context 
of the determined coupling conditions. These conditions were used to generate a piperazine linked 
scaffold – albeit very long reaction times were required. The piperazine linked anthraquinone-
Figure 18: N,N’-dimethylethylenediamine anthraquinone-phenothiazine conjugate synthesis.  
Figure 17: Piperazinyl methylene blue (left) 
and 2-piperazinyl-9,10-dialkoxyanthracene 
(right). Combination of these two components 
through the two amines of piperazine would result 
in a complete scaffold for singlet oxygen-
mediated photorelease. 
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phenothiazine conjugate was then used to synthesize a dialkoxyanthracene scaffold, albeit in low yields  
(Figure 19). At this point, a molecule had been developed that was a single Boc deprotection and 
oxidation away from the envisioned scaffold for singlet oxygen-mediated photorelease. Unfortunately, 
Boc deprotection of this product proved too harsh, giving a range of products, from which the final 
photocage could not be isolated.  
In an attempt to circumvent the Boc deprotection issue, a number of alternative protecting groups 
were explored. NVOC-dibromophenothiazine and benzyl-dibromophenothiazine could both be 
obtained with reasonable purity as a starting point for scaffold development, however, only deprotection 
of the benzyl-dibromophenothiazine proceeded cleanly. Subsequent coupling to 2-piperazinyl-
anthraquinone and dialkoxyanthracene formation were both successful starting with benzyl-
dibromophenothiazine, however, deprotection of the final scaffold once again proved problematic. 
These results suggested that the final scaffold was either too unstable or too difficult to isolate. 
In a final attempt to work around this issue, thiol substitution was explored, as the 9,10-
dithioanthracenes had been shown to be more stable. Unfortunately, the thiol compounds proved equally 
difficult to work with. At this point, despite being close to a complete scaffold, it became apparent that a 
major synthetic rework would be required. Although development of such a scaffold still has significant 
merit, a new synthetic strategy will be required to fully explore singlet oxygen-mediated photochemical 
release in the context of a phenothiazine scaffold.  
4.4 Conclusion  
The principle of singlet oxygen-mediated photorelease is still relatively unexplored. Despite the initial 
findings of Schnermann and coworkers, there has not yet been any significant follow-up by the 
photochemical community. This is likely because the development of scaffolds capable of both 
Figure 19: Synthesis of a piperazine linked dialkoxyanthracene-phenothiazine conjugate.   
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generating singlet oxygen and mediating photorelease is a significant challenge. To address this deficiency 
in the field, attempts were made to generate such a scaffold by combining the singlet oxygen sensitization 
capabilities of phenothiazine derivatives, such as methylene blue, with the singlet oxygen sensitivity of 
moieties such as 9,10-dialkoxyanthracene. In specific, a long wavelength phenothiazine derivative known 
as o-DAP was initially explored as a promising singlet oxygen generator. When it was shown that previous 
reports of singlet oxygen generation could not be recapitulated, functionalizable methylene blue 
derivatives were evaluated instead. To complement these chromophores, heteroatom modified 
anthracenes were investigated as singlet oxygen sensitive cages. It was demonstrated that 9,10-
dialkoxyanthracene, 9,10-diaminoanthracene, and 9,10-dithioanthracene all collapsed in the presence of 
singlet oxygen, liberating protected groups. Attempts were then made at combining anthracene 
derivatives and a phenothiazine derivative into a single molecule capable of undergoing singlet oxygen-
mediated photorelease. Unfortunately, despite significant progress on this front, a complete scaffold was 
not obtained. Despite this setback, the field of singlet oxygen-mediated photorelease is still filled with 
opportunity, and the described system is worth revisiting in the context of a different synthetic route.     
4.5 Materials and Methods 
4.5.1 Materials 
 Commercial reagents and solvents were purchased from Sigma-Aldrich, VWR, and Thermo-Fisher 
Scientific and used as received. Deuterated solvents were purchased from Cambridge Isotope 
Laboratories and used without further purification. Reactions involving air or moisture sensitive reagents 
were run under argon, with samples purged of air prior to use. Flash chromatography was performed 
using neutral silica gel from Merck (230-400 mesh). TLC analysis was performed with plates from Merck 
(60 A pore size, F254, 0.25 mm).  
4.5.2 Instrumentation 
 1H NMR spectra were obtained using Varian NMR instruments. Chemical shifts are reported in parts 
per million (ppm, δ) referenced to the residual 1H resonance of the solvent. Splitting patterns are 
designated as follows: s, singlet; br, boad; d, doublet; dd, doublet of doublets; t, triplet; q, quartet; m, 
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multiplet. Mass spectrometry data were obtained using an Agilent 1100 LC/MSD equipped with an ESI-
APCI source. LC-MS runs were performed using a binary solvent system consisting of Omnisolv 
acetonitrile and ultrapure water with .1% acetic acid. An Agilent C-18 column was used for separations. 
For crude product mixtures an LCT Premier XE ESI-TOF-MS was used to validate product formation 
through injection of crude material. Irradiations were performed using LED-driver combinations 
obtained from Thor labs. A 660 nm LED was used to irradiate methylene blue and its derivatives, and a 
980nm LED was used to irradiate o-DAP and its derivatives. UV-VIS spectra were obtained using a Cary 
UV-VIS spectrometer.  
4.5.3 Anthracene Derivative Irradiation and HPLC Analysis 
 All anthracene derivatives were evaluated in the context of methylene blue irradiation. Specifically, 
solutions in methanol were generated that contained both heteroatom functionalized anthracenes (at 
various concentrations depending on solubility) and methylene blue. A concentration of methylene blue 
was used that produced an absorbance of 1.0 at 660 nm. These solutions were irradiated with a 660 nm 
LED while stirring in Starna quartz cuvettes, and kept in the dark besides. Following irradiation, solutions 
were loaded onto the LC/MS. Freeze-pump-thaw samples were generated using glassware designed at 
the Caltech glass shop. Analysis of the 2-piperazine-9,10-dialkoxyanthracene and the 9,10-
dithioanthracene irradiation experiments was carried out using a 70%-95% solvent gradient (where the 
percent represents the percent acetonitrile) over the course of 10 minutes. These conditions failed to 
elute the 9,10-diaminoanthracene molecule, therefore a 30 min 70%-95% run was used. Comparisons 
were made between control, freeze-pump-thawed, and irradiated samples at the same initial 
concentration.  
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4.5.4 Syntheses 
 
3,7-dibromo-phenothiazine 
In a 500 ml round bottom flask, 5 grams of phenothiazine were added to 250 ml of acetic acid. 3.2 
mL of bromine (2.5 equivalents) were subsequently added to this solution. The solution turned purple, 
becoming heterogenous and difficult to stir. Reaction was stirred for two hours. After two hours, 5 ml of 
water and 3.16 grams (2 equivalents) of sodium sulfite were added. The reaction was allowed to stir for 
an additional 15 minutes, at which point 4 equivalents of 1 M sodium hydroxide were added. The reaction 
was stirred until the purple color had faded to gray and a precipitate had formed. This product was 
filtered, washed briefly with acetone, then constantly washed with hexanes. Obtained a light blue/green 
powder upon drying via vacuum filtration. 1H-NMR (300 MHz, CDCl3) δ: 8.83 (s, 1H), 7.13 (m, 4H), 
6.56 (d, 2H). ESI-MS (MH+) calculated: 355.8, found 355.9. 
 
 N-Boc-3,7-dibromophenothiazine 
To 2 grams of 3,7-dibromophenothiazine in 100 ml of acetonitrile in a 250 ml round bottom flask 
was added 1.5 grams (1.2 equivalents) of di-tert-butyl dicarbonate (Boc Anhydride). A catalytic amount 
of DMAP (100 mg, .1 equivalent) was also added, and the reaction was allowed to stir overnight. A peach 
liquid with a white precipitate was obtained after overnight stirring. The precipitate was isolated and 
washed with additional acetonitrile and hexanes. It was then taken up in DCM, and run on a 100% DCM 
silica gel column. The product was isolated as a white, UV active spot. 1H-NMR (300 MHz, CDCl3) δ: 
7.48 (d, 2H), 7.40 (m, 4H), 1.57 (s, 9H). ESI-MS (MH+) calculated: 457.2, found 457.6 
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N-Boc-3,7-bis(4-aminophenyl)-phenothiazine 
A 25 ml, flame-dried round bottom flask was charged with 100 mg of N-Boc-3,7-
dibromophenothiazine.  To this was added 105 mg (2.2 equivalents) of 4-aminophenylboronic acid 
pinacol ester, an excess of sodium carbonate (100 mgs, roughly 4 equivalents) and a catalytic amount of 
palladium acetate (1 mg) and tri(o-tolyl)phosphine (10mg). The solids were dissolved in a mixture of 5:1 
dioxanes:water, with both solvents having been previously deoxygenated. The reaction was run at heat 
(80° C) for 4 hours and monitored by TLC as well as LC/MS. Upon disappearance of the starting 
material, the reaction was quenched via extraction into DCM. After pumping down, the product was 
purified using a 2:1 hexanes:acetone silica column. The product was isolated as a slightly off-white 
powder. 1H-NMR (300 MHz, CDCl3) δ: 7.56 (m, 6H), 7.45 (m, 4H), 6.75 (m, 4H), 1.57 (s, 9H). ESI-MS 
(MH+) calculated: 482.2, found 482.4.  
 
3,7-bis(4-aminophenyl)-phenothiazine 
 A 25 ml round bottom flask was charged with 20 mg of N-Boc-3,7-bis(4-aminophenyl)-
phenothiazine, which was subsequently charged with DCM containing 10% TFA. The reaction was 
monitored by LC/MS. After 4 hours, the starting material had disappeared and was replaced with a 
combination of 3,7-bis(4-aminophenyl)-phenothiazine and what appeared to be an oxidized version. The 
10% TFA in DCM solution was pumped off, then brought back up in DCM. This was done three times. 
After the third time, the DCM was washed with saturated sodium bicarbonate, yielding a yellow brown 
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product. An NMR spectrum of this product could not be obtained. ESI-MS (MH+) calculated: 382.1, 
found 382.4.  
 
3,7-bis(4-aminophenyl)-phenothiazinium 
A 10 ml round bottom flask was charged with 10 mg of 3,7-bis(4-aminophenyl)-phenothiazine, to 
which an excess of I2 (10 equivalents) in CHCl3 was added. The oxidation proceeded instantaneously by 
UV-VIS, but was allowed to proceed for an hour to ensure complete conversion. Product was isolated 
as a black solid via vacuum filtration and washed with DCM to remove excess iodine. An NMR spectrum 
of this product could not be obtained. ESI-MS (M+) calculated: 380.1, found 380.2. 
 
N-Boc-3,7-bis(4-dimethylaminophenyl)-phenothiazine 
 A 25 ml, flame-dried round bottom flask was charged with 100 mg of N-Boc-3,7-
dibromophenothiazine.  To this was added 120 mg (2.2 equivalents) of 4-aminophenylboronic acid 
pinacol ester, an excess of sodium carbonate (100 mgs, roughly 4 equivalents) and a catalytic amount of 
palladium acetate (1 mg) and tri(o-tolyl)phosphine (10mg). The solids were dissolved in a mixture of 5:1 
dioxanes:water, with both solvents having been previously deoxygenated. The reaction was run at heat 
(80° C) for 4 hours and monitored by TLC as well as LC/MS. Upon disappearance of the starting 
material, the reaction was quenched via extraction into chloroform. After pumping down, the product 
was purified using a chloroform column. The product was isolated as a slightly off-white powder. 1H-
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NMR (300 MHz, CDCl3) δ: 7.48 (m, 10H), 6.75 (m, 4H), 2.17 (s, 12H), 1.57 (s, 9H). ESI-MS (MH+) 
calculated: 538.2, found 538.4. 
 
3,7-bis(4-dimethylaminophenyl)-phenothiazine 
A 25 ml round bottom flask was charged with 100 mg of N-Boc-3,7-bis(4-dimethylaminophenyl)-
phenothiazine, which was subsequently charged with DCM containing 10% TFA. The reaction was 
monitored by LC/MS. After 2 hours, the starting material had disappeared and was replaced with what 
appeared to be predominately product. The 10% TFA in DCM solution was pumped off, then brought 
back up in DCM. This was done three times. After the third time, the DCM was washed with saturated 
sodium bicarbonate, yielding a yellow brown product. 1H-NMR (300 MHz, CDCl3) δ: 7.63 (m, 10H), 
7.46 (m, 4H), 2.17 (s, 12H), 1.57 (s, 9H). ESI-MS (MH+) calculated: 438.2, found 438.1. 
 
3,7-bis(4-dimethylaminophenyl)-phenothiazinium 
A 10 ml round bottom flask was charged with 50 mg of 3,7-bis(4-aminophenyl)-phenothiazine, to 
which an excess of I2 (10 equivalents) in CHCl3 was added. The oxidation proceeded instantaneously by 
UV-VIS, but was allowed to proceed for an hour to ensure complete conversion. Product was isolated 
as a black solid via vacuum filtration and washed with DCM to remove excess iodine. 1H-NMR (300 
MHz, DMSO-D6) δ: 8.72 (m, 2H), 8.48 (m, 2H), 8.16 (m, 6H), 6.97 (m, 4H), 3.18 (s, 12H). ESI-MS (M+) 
calculated: 436.1, found 436.1. 
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Tetraethyl-2,2',2'',2'''-((N-Boc-3,7-bis(4-aminophenyl)phenothiazine)tetraacetate) 
100 mg of N-Boc-3,7-bis(4-aminophenyl)-phenothiazine were added to a 10 ml round bottom flask 
and subsequently dissolved in DMSO. A large excess of ethyl iodoacetate (250 μl, 10 equivalents) was 
added to the reaction mixture, which was set to 80°C and allowed to stir overnight. A range of alkylation 
patterns was observed by LC/MS, however, after 24 hours a majority of the starting material had become 
the tetraalkylated product. The reaction was then taken up in DCM, and washed three times with water, 
then once with brine. The solution was pumped down, yielding a slightly off white solid. This solid was 
then subjected to column chromatography, and eluted with a 0-5% methanol in DCM gradient. The 
obtained product was pure by NMR and mass spectrometry. 1H-NMR (300 MHz, CDCl3) δ: 7.48 (m, 
10H), 6.68 (m, 4H), 4.24 (q, 8H), 4.18 (s, 8H). 1.27 (M, 21 H). ESI-MS (MH+) calculated: 826.3, found 
826.4. 
 
Tetraethyl-2,2',2'',2'''-((-bis(4-aminophenyl)phenothiazine)tetraacetate  
A 25 ml round bottom flask was charged with 50 mg of N-Boc-3,7-bis(4-dimethylaminophenyl)-
phenothiazine, which was subsequently incubated with DCM containing 10% TFA. The reaction was 
monitored by LC/MS. After 2 hours, the starting material had disappeared and was replaced with what 
appeared to be predominately product. The 10% TFA in DCM solution was pumped off, then brought 
back up in DCM. This was done three times. After the third time, the DCM was washed with saturated 
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sodium bicarbonate, yielding a yellow brown product. A clean 1H NMR was not obtained, and this 
product was carried straight through into the oxidation step. ESI-MS (MH+) calculated: 726.3, found 
726.2. 
 
Tetraethyl-2,2',2'',2'''-((-bis(4-aminophenyl)phenothiazinium)tetraacetate 
A 10 ml round bottom flask was charged with 25 mg of 3,7-bis(4-aminophenyl)-phenothiazine, to 
which an excess of I2 (10 equivalents) in CHCl3 was added. The oxidation proceeded instantaneously by 
UV-VIS, but was allowed to proceed for an hour to ensure complete conversion. Product was isolated 
as a black solid via vacuum filtration and washed with DCM to remove excess iodine. 1H-NMR (300 
MHz, DMSO-D6) δ: 9.00 (s, 2H), 8.60 (d, 2H), 8.40 (d, 2H), 8.15 (d, 4H), 6.80 (d, 4H), 4.42 (s, 8H) 4.12 
(q, 8H), 1.20 (m, 21H). ESI-MS (M+) calculated: 724.3, found 724.3. 
 
Generalized protocol for amine addition to oxidized phenothiazine (shown in the context of Boc-
piperazine) 
 
 Amine (2 equivalents) was added to phenothiazinium iodide (1 equivalent) in methanol at room 
temperature. If the amine contained more than one amine, its second amine was Boc protected. The 
reactions were run under argon in the dark. After six hours the reaction was pumped down and evaluated 
for addition. In the event that only a single addition was observed, the product was taken up in DCM 
and base was added dropwise in the form of triethylamine (3 equivalents). Additional amine was then 
added to this solution (3 equivalents) and stirred overnight at room temperature. The organic layer was 
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then washed with water (3x), pumped down, and run on a 0-10% methanol in DCM column. When 
necessary, subsequent Boc deprotection was run with 10% TFA in DCM.  1H-NMR for 3,7-dipiperazinyl-
phenothiazinium (300 MHz, CDCl3) δ: 8.08 (d, 2H), 7.90 (s, 2H), 7.76 (M, 2H), 4.15 (m, 8H), 3.48 (m, 
8H). ESI-MS (MH+) calculated: 366.2, found 366.3. 
 
(Z)-2,2'-(ethene-1,2-diylbis(sulfanediyl))bis(ethanol) 
 To 0.8 grams (2.5 equivalents) of NaOH in ethanol was added 1.8 ml (2 equivalents) of β-
mercaptoethanol in a 100 ml round bottom flask. This was stirred on ice for thirty minutes, at which 
point 1 gram of dichloroethylene was suspended in cold ethanol and added to the solution. The resulting 
solution was heated to 80°C and allowed to stir overnight. The reaction was monitored by TLC. After 18 
hours, the starting material had disappeared by TLC and an orange solution remained. This solution was 
diluted into water, then extracted three times with ether. After pumping off the ether, the resulting oil 
was diluted directly onto a 70:30 ethyl acetate:hexanes column. The isolated product still contained β-
mercaptoethanol starting material by NMR, so the column was run a second time to separate the desired 
product away from the impurity. 1H-NMR (300 MHz, CDCl3) δ: 6.17 (s, 2H), 4.87 (s, 2H), 3.69 (t, 4H), 
2.84 (t, 4H). ESI-MS (MH+) not obtained. 
 
9,10-dialkoxyanthracenebispropanol 
 13 ml of H2O was added to a 50 mL round bottom flask, then deoxygenated under vacuum and 
flushed with argon. Subsequently 13 mL of deoxygenated DCM was added. This combination was stirred 
and deoxygenated together for a second time. Next, 220 mgs of anthraquinone, 370 mg of Na2S2O4 (2.1 
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equivalents), and 4 drops of Adogen 464 were added to the solution. This solution was stirred for 5 
minutes, at which point 400 mg (10 equivalents) of NaOH were added. The solution turned red. After 
another 5 minutes, 1 gram (5 equivalents) of 3-iodopropanol was added. The reaction was followed by 
TLC, and allowed to stir overnight. After complete conversion of the starting material, the reaction was 
diluted into water and washed three times with DCM. The combined organic portion was pumped down, 
yielding an oil. This oil was purified on a 50:50 hexanes:ethyl acetate column, eluting as a yellow fraction. 
1H-NMR (300 MHz, CDCl3) δ: 8.25 (m, 4H), 7.53 (m, 4H), 4.65 (t, 2H), 4.19 (m, 4H), 3.77 (m, 4H), 2.11 
(m, 4H). ESI-MS (MH+) not obtained. 
 
N,N,N’,N’-tetrapropylanthracene-9,10-diamine 
 To 250 mg of 9,10-dibromoanthracene was added 200 mg (4 equivalents) of KOtBu in dioxane with 
a catalytic amount of PEPPSI-IPR catalyst in a 25 ml round bottom flask. This solution was heated gently 
to solubilization, at which point 250 µL of dipropylamine (4 equivalents) was added. The reaction was 
subsequently set to reflux overnight and monitored at intervals by TLC and LC/MS. Notably, a 30 min 
LC/MS run was required to observed product elution. The reaction was quenched by dilution in water, 
and the product extracted into DCM. The organic layer was washed three times with water, pumped 
down, and then loaded in DCM onto a 30% ethyl acetate in hexanes column. The desired product 
coeluted with an impurity, so a second hexanes column was run to obtained completely pure product. 
1H-NMR (300 MHz, CDCl3) δ: 8.43 (m, 4H), 7.42 (m, 4H), 3.41 (m, 8H), 1.56 (m, 8H), .82 (m, 8H). ESI-
MS (MH+) calculated: 377.3, found 377.5. 
 
 
 
 
 
  
89 
 
 
9,10-anthracenediacetate 
To 500 mg of anthraquinone was added 1.6 grams of zinc dust (>10 equivalents) and 3.3 grams of 
potassium carbonate (10 equivalents) in a 100 ml round bottom flask. This was stirred in THF under 
argon, and subsequently 2.5 ml (10 equivalents) of acetic anhydride was added. This reaction was stirred 
for 3 hours, at which point complete conversion was observed by TLC. The reaction was worked up by 
filtering to remove suspended zinc dust, quenching with .1 M HCl for 1 hour, then extracting with DCM. 
After washing the organic layer three times, the solution was pumped down. Further purification was not 
required. 1H-NMR (300 MHz, CDCl3) δ: 7.95 (m, 4H), 7.53 (m, 4H), 2.64 (s, 6H). ESI-MS (MH+) not 
obtained.  
 
9,10-diethylthioanthracene 
 To 200 mgs of 9,10-anthracenediacetate in toluene in a 50 mL round bottom flask was added an 
excess of p-toluenesulfonic acid and ethane thiol. The reaction was set to reflux and allowed to proceed 
for 4 hours. Over this time, the reaction mixture went from clear to yellow. After 4 hours the reaction 
was diluted in ethyl acetate then washed with water three times. The organic layer was pumped down, 
taken up in a small amount of DCM, and loaded onto a DCM column. The eluted product was still 
contaminated with a small amount of ethane thiol, so a second column (0-2% ethyl acetate in hexanes) 
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was run. A high vac was used to remove final traces of ethane thiol.  1H-NMR (400 MHz, CDCl3) δ: 9.11 
(m, 4H), 7.64 (m, 4H), 2.94 (q, 4H), 1.18 (t, 6H). ESI-MS (MH+) calculated: 299.1, found 299.5. 
 
2-piperazinylanthraquinone 
 200 mg of 2-chloroanthraquinone was added to 700 mg of piperazine (10 equivalents) in a 25 ml 
round bottom flask. To this, ethanol was added, but not enough for complete solubilization of the 2-
chloroanthraquinone at room temperature. The mixture was set to reflux, and transitioned from a yellow 
starting material to a dark red product. Ethanol was allowed to boil down. Upon cooling, the slurry was 
dissolved in DCM and washed three times with water. A 0-10% methanol in DCM column was run to 
isolate pure product. 1H-NMR (300 MHz, CDCl3) δ: 8.25 (m, 2H), 8.15 (d, 1H), 7.73 (m, 2H), 7.62 (d, 
1H), 7.13 (dd, 1H), 3.44 (m, 4H), 3.03 (m, 4H). ESI-MS (MH+) calculated: 293.1, found 293.2. 
 
2-chloro-9,10-dialkoxyanthracenebispropanol 
13 ml of H2O was added to a 50 mL round bottom flask, then deoxygenated under vacuum and 
flushed with argon. Subsequently 13 mL of deoxygenated DCM was added. This combination was stirred 
and deoxygenated together for a second time. Next, 250 mgs of 2-chloroanthraquinone, 370 mg of 
Na2S2O4 (2.1 equivalents), and 4 drops of Adogen 464 were added to the solution. This solution was 
stirred for 5 minutes, at which point 400 mg (10 equivalents) of NaOH were added. The solution turned 
red. After another 5 minutes, 1 gram (5 equivalents) of 3-iodopropanol was added. The reaction was 
followed by TLC, and allowed to stir overnight. After complete conversion of the starting material, the 
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reaction was diluted into water and washed three times with DCM. The combined organic portion was 
pumped down, yielding an oil. This oil was purified on a 50:50 hexanes:ethyl acetate column, eluting as a 
yellow fraction. 1H-NMR (300 MHz, CDCl3) δ: 8.26 (m, 4H), 7.55 (m, 3H), 4.66 (t, 2H), 4.18 (m, 4H), 
3.76 (m, 4H), 2.11 (m, 4H). ESI-MS (MH+) not obtained. 
 
N-Boc-2-piperazinylanthraquinone 
200 mg of 2-chloroanthraquinone was added to 1.5 g of Boc-piperazine (10 equivalents) in a 25 ml 
round bottom flask. To this, ethanol was added, but not enough for complete solubilization of the 2-
chloroanthraquinone at room temperature. Triethylamine, 300 µl, was also added to facilitate the reaction. 
The mixture was set to reflux, and transitioned from a yellow starting material to a dark red product. 
Ethanol was allowed to boil down. Upon cooling, the slurry was dissolved in DCM and washed once 
with water, washed once with saturated ammonium chloride solution, and then three more timed with 
water. A 0-10% methanol in DCM column was run to isolate pure product. 1H-NMR (300 MHz, CDCl3) 
δ: 8.16 (m, 2H), 8.04 (d, 1H), 7.87 (m, 2H), 7.52 (d, 1H), 7.32 (dd, 1H), 3.5 (m, 8H), 1.42 (s, 9H). ESI-MS 
(MH+) calculated: 393.2, found 393.4. 
 
N-Boc-2-piperazinyl-9,10-dialkoxyanthracenebispropanol 
13 ml of H2O was added to a 50 mL round bottom flask, then deoxygenated under vacuum and 
flushed with argon. Subsequently 13 mL of deoxygenated DCM was added. This combination was stirred 
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and deoxygenated together for a second time. Next, 400 mgs of N-Boc-2-piperazinylanthraquinone, 370 
mg of Na2S2O4 (2.1 equivalents), and 4 drops of Adogen 464 were added to the solution. This solution 
was stirred for 5 minutes, at which point 400 mg (10 equivalents) of NaOH were added. The solution 
turned red. After another 5 minutes, 1 gram (5 equivalents) of 3-iodopropanol was added. The reaction 
was followed by TLC, and allowed to stir overnight. After complete conversion of the starting material, 
the reaction was diluted into water and washed three times with DCM. The combined organic portion 
was pumped down, yielding an oil. This oil was immediately subjected to Boc deprotection. 1H-NMR 
and ESI-MS (MH+) not obtained. 
 
2-piperazinyl-9,10-dialkoxyanthracenebispropanol 
Crude N-Boc-2-piperazinyl-9,10-dialkoxyanthracenebispropanol was taken up in methanol and 
diluted down in a combination of water and HCl (10%). Deprotection reaction proceeded slowly but 
cleanly. Product formation was observed by both TLC and LC/MS. After overnight deprotection, the 
reaction was worked up by dilution into a saturated sodium bicarbonate solution and extracted into DCM. 
Some side product formation was observed upon work up. Crude product was isolated and run on base-
treated silica column using a 0-10% methanol in DCM gradient.   1H-NMR (300 MHz, CDCl3) δ: 8.19 
(m, 3H), 7.44 (m, 4H), 4.29 (m, 4H), 4.12 (m, 4H), 3.72 (m, 4H), 3.39 (m, 4H), 3.17 (m, 2H), 2.27 (m, 
2H). ESI-MS (MH+) calculated: 413.2, found 413.4. 
 
2-N,N’-dimethylethylenediamineanthraquinone 
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 200 mg of 2-chloroanthraquinone was added to 700 mg of N,N’-dimethylethylenediamine (10 
equivalents) in a 25 ml round bottom flask. To this, ethanol was added, but not enough for complete 
solubilization of the 2-chloroanthraquinone at room temperature. The mixture was set to reflux, and 
transitioned from a yellow starting material to a dark red product. Ethanol was allowed to boil down. 
Upon cooling, the slurry was dissolved in DCM and washed three times with water. A 0-10% methanol 
in DCM column was run to isolate pure product. 1H-NMR (300 MHz, CDCl3) δ: 8.24 (m, 2H), 8.13 (d, 
1H), 7.71 (m, 2H), 7.44 (d, 1H), 6.97 (dd, 1H), 3.62 (t, 2H), 3.15 (s, 3H), 2.86 (t, 2H), 2.48 (s, 3H). ESI-
MS (MH+) calculated: 295.1, found 295.1. 
 
N-Boc-3,7-bis((2-((anthraquinone)(methyl)amino)ethyl)(methyl)amino)phenothiazine 
 In a 25 ml round bottom flask, 100 mg of N-Boc-3,7-dibromophenothiazine was dissolved in 
deoxygenated dioxanes and water (5:1 ratio). To this solution was added 500 mg (8 equivalents) of 2-
N,N’-dimethylethylenediamineanthraquinone, 250 mg of KOtBu (10 equivalents), 10 mg of RuPhos, and 
a catalytic amount of XPhos Pd G2. The reaction was set to reflux, and allowed to proceed overnight. 
The reaction was observed by TLC, and by the removal of aliquots that were subjected to acid for Boc 
deprotection and subsequent MS analysis. After observing significant product formation, reaction was 
diluted in DCM and washed three times with water. The organic portion was pumped down, taken up in 
DCM, and then pumped down with silica to generate a powder for dry loading onto a column. A 0-10% 
DCM in methanol column was run, and a number of red and orange spots were isolated. Aliquots from 
these spots were subjected to Boc deprotection by TFA, and subsequent mass spectrometry analysis. 
Using this method, the doubly modified product was successfully identified as an orange compound, and 
separated from the singly modified product. Without TFA deprotection, the obtained mass spectrum was 
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uninterpretable. 1H-NMR (300 MHz, CDCl3) δ: 8.28 (m, 4H), 8.24 (d, 2H), 7.75 (m, 4H), 7.50 (d, 2H), 
7.30 (m, 2H), 6.92 (d, 2H), 6.59 (m, 2H), 3.77 (m, 4H), 3.68 (m, 4H), 3.11 (s, 6H), 2.97 (s, 6H), 1.51 (s, 
9H). ESI-MS (MH+) not obtained. 
 
N-Boc-3,7-bis((2-piperazinylanthraquinone)phenothiazine 
 In a 25 ml round bottom flask, 100 mg of N-Boc-3,7-dibromophenothiazine was dissolved in 
deoxygenated dioxanes and water (5:1 ratio). To this solution was added 500 mg (8 equivalents) of 2-
piperazinylathranquinone, 250 mg of KOtBu (10 equivalents), 10 mg of RuPhos, and a catalytic amount 
of XPhos Pd G2. The reaction was set to reflux, and allowed to proceed for 48 hours. The reaction was 
observed by TLC, and by the removal of aliquots that were subjected to acid for Boc deprotection and 
subsequent MS analysis. After observing significant product formation, reaction was diluted in DCM and 
washed three times with water. The organic portion was pumped down, taken up in DCM, and then 
loaded onto a silica gel column. Product was eluted with a 0-10% DCM in methanol gradient, and a 
number of red and orange spots were isolated. Aliquots from these spots were subjected to Boc 
deprotection by TFA, and subsequent mass spectrometry analysis. Using this method, the doubly 
modified product was successfully identified as an orange compound, and separated from the singly 
modified product. Without TFA deprotection, the obtained mass spectrum was uninterpretable. 1H-
NMR (300 MHz, CDCl3) δ: 8.30 (m, 4H), 8.21 (d, 2H), 7.77 (m, 4H), 7.68 (d, 2H), 7.45 (m, 2H), 7.20 (m, 
2H) 6.92 (m, 4H), 3.65 (m, 8H), 3.37 (m, 8H), 1.51 (s, 9H). ESI-MS (MH+) not obtained. 
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N-Boc-3,7-bis(2-piperazinyl-9,10-dialkoxyanthracenebispropanol)phenothiazine 
13 ml of H2O was added to a 50 mL round bottom flask, then deoxygenated under vacuum and 
flushed with argon. Subsequently 13 mL of deoxygenated DCM was added. This combination was stirred 
and deoxygenated together for a second time. Next, 200 mgs of N-Boc-3,7-bis((2-
piperazinylanthraquinone)phenothiazine, 80 mg of Na2S2O4 (2.1 equivalents), and 4 drops of Adogen 
464 were added to the solution. This solution was stirred for 5 minutes, at which point 45 mg (10 
equivalents) of NaOH were added. The solution turned red. After another 5 minutes, 100 mg (5 
equivalents) of 3-iodopropanol was added. The reaction was followed by TLC and allowed to stir 
overnight. After complete conversion of the starting material, the reaction was diluted into water and 
washed three times with DCM. The combined organic portion was pumped down, yielding an oil. 
Purified the product using a 0-10% methanol in DCM column. 1H-NMR (400 MHz, CDCl3) δ: 8.26 (m, 
4H), 7.54 (m, 4H), 7.47 (m, 4H), 7.42 (m, 4H), 6.98 (m, 4H), 4.38 (m, 8H), 4.21 (m, 8H), 3.58 (m, 8H), 
3.46 (m, 8H), 2.35 (m, 8H). ESI-MS (MH+) not obtained. 
 
N-benzyl-3,7-dibromophenothiazine  
 A 100 ml round bottom flask was charged with 500 mg of 3,7-dibromophenothiazine and 200 mg 
(1.2 equivalents) of KOtBu, which were subsequently dissolved in acetone. A dark red solution was 
obtained. 350 µl (2 equivalents) of benzyl bromide was then added, and the color rapidly faded. 
Disappearance of the starting material was followed by TLC. After 1 hour, the product was precipitated 
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out via water addition and washed with cold water to remove impurities. The product was subsequently 
taken up in DCM and run through a silica plug to obtain pure product. 1H-NMR (300 MHz, CDCl3) δ: 
7.41 (m, 2H), 7.33 (m, 3H), 7.24 (d, 2H), 7.11 (dd, 2H), 6.53 (d, 2H), 5.05 (s, 2H). ESI-MS (MH+) not 
obtained. 
 
N-NVOC-3,7-dibromophenothiazine  
A 25 ml round bottom flask was charged with 200 mg of 3,7-dibromophenothiazine and 60 mg (0.9 
equivalents) of KOtBu, which were subsequently dissolved in acetone. A dark red solution was obtained. 
150 mg (1 equivalent) of NVOC-chloride was then added, and the color rapidly faded. Disappearance of 
the starting material was followed by TLC. After 4 hours, the reaction was taken up in DCM and washed 
with water. The crude was then taken up in DCM and run on a DCM column. 1H-NMR (300 MHz, 
CDCl3) δ: 7.71 (s, 1H), 7.52 (m, 2H), 7.43 (m, 4H), 6.68 (s, 1H), 5.29 (s, 2H), 3.94 (s, 3H), 3.78 (s, 3H). 
ESI-MS (MH+) not obtained.  
 
N-p-methoxybenzyl-3,7-dibromophenothiazine  
A 25 ml round bottom flask was charged with 200 mg of 3,7-dibromophenothiazine and 250 mg (4 
equivalents) of KOtBu, which were subsequently dissolved in acetonitrile. A dark red solution was 
obtained. 100 µl (1.25 equivalents) of p-methoxybenzyl chloride was then added, and the color faded. 
Disappearance of the starting material was followed by TLC. After 2 hours, the reaction was taken up in 
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DCM and washed with water. The crude was then taken up in DCM and run on a 0-50% DCM in 
hexanes column. 1H-NMR  and ESI-MS (MH+) could not be obtained.  
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Chapter 5: Development of Heptamethine-Based Charge-Transfer Dyes for Long-
Wavelength (NIR I/II) Photochemistry 
 
5.1 Abstract 
The ability to perform photochemistry at longer wavelengths would afford a range of new biological 
applications, enabled by the better penetration of light into the body. However, the development of long 
wavelength photochemistry in the near-infrared optical windows remains a significant challenge. Towards 
this end, the development of a new dye capable of generating singlet oxygen was explored. A 
heptamethine-based charge-transfer dye was designed based on previous evidence of triplet state 
formation in orthogonal charge-transfer partners, and the ability of this dye to generate a charge-transfer 
state was predicted computationally. This dye, IR-1061-pyridinium, was subsequently synthesized and 
evaluated for its ability to generate singlet oxygen. Although it was unstable to the irradiation conditions 
– making it difficult to determine the exact effects of irradiation – irradiation of the dye suggested singlet 
oxygen formation, prompting the development of a more stable derivative, IR-1061-acridinium. This dye 
was shown to be stable under irradiation conditions, and generated singlet oxygen upon irradiation at 
1064 nm. Despite some limitations on these dyes, the observed reactivity marks a significant step in the 
development of long wavelength photochemistry, as no single photon photochemistry has previously 
been described above 900 nm.  
5.2 Introduction 
5.2.1 Near-Infrared Photochemistry 
The rational design of new photochemical reactivity is challenging, but extremely important given the 
burgeoning number of photochemical applications. To complement a host of impressive work being 
done in the visible spectrum1–6, novel photochemical reactivity based on near-infrared (NIR) light is 
required. Although the development of NIR-absorbing photoremovable protecting groups remains the 
primary goal in the Dougherty lab, an interim step – one that could potentially guide the development of 
future photoremovable protecting groups – would be the development of NIR singlet oxygen generators.  
Singlet oxygen – the first excited state of O2 – has significant therapeutic potential. It is already 
used in a variety of clinical applications, from photodynamic therapy7 to corneal crosslinking8, and new 
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applications continue to emerge. For most therapeutic applications, singlet oxygen is generated in situ 
via excitation of a photosensitizer. Although this affords unmatched spatiotemporal control over the 
reactive singlet oxygen molecules9, it constrains applications to areas that can be accessed by light. 
Compared to visible light, NIR light offers several advantages, most notably significantly greater light 
penetration in the body.10,11 Although a number of fluorophores are now being designed with this in 
mind12,13, there are few small molecule NIR chromophores capable of generating singlet oxygen past 
800 nm, and those that can do not absorb significantly above 800 nm.11,14,15 In fact, no single photon 
chemistry has previously been observed above 900 nm. Different methods – such as two-photon 
excitation16 and upconverting nanoparticles17 –  have been proposed to circumvent this issue, but a 
need remains for small molecules capable of directly generating singlet oxygen using NIR light. 
5.2.2 Photochemistry of Charge-Transfer States 
 Inspiration for a class of chromophores with reactivity beyond 900 nm came from previous reports 
that demonstrated the ability of dyes containing an orthogonal charge-transfer partner to generate a triplet 
state.18–20 Although charge-transfer dyes that mediate ISC are actively being explored, there is a lack of 
consensus on the required characteristics.21 Interestingly, to this point few attempts have focused on the 
characteristic that made earlier systems unique: sterically confined charge transfer partners. A clear 
example of this phenomenon was demonstrated in a series of BODIPY derivatives synthesized and 
characterized by the Ziessel group. By comparing a standard BODIPY dye to one functionalized at the 
para position with an N-methylpyridinium cation (Figure 1A), the authors were able to realize a 
substantial increase in the triplet state quantum yield, from nearly zero in the former to approximately 
0.75 in the latter.19 The authors propose a mechanism by which the BODIPY dye is excited into a 
traditional singlet state (S1), but rapidly relaxes to a charge-transfer state (CTS) involving the orthogonal 
N-methylpyridinium.19 This charge-transfer state is long lived and preferentially relaxes into an excited 
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triplet state (T1) (Figure 1B).19  Although the 
authors’ goal was to explore the mechanism of 
triplet formation, their results suggested that 
singlet oxygen sensitization was occurring under 
atmospheric conditions. This phenomenon has 
been reported using dyes that absorb ultraviolet 
and visible light, but it has never been expanded 
to near-infrared absorbing substrates.18–20  
5.3 Results and Discussion  
5.3.1 Computational Evaluation of Heptamethine Charge-Transfer Dyes   
Heptamethine dyes present an opportune starting point for charge-transfer capable NIR dyes.  A 
diverse class of chromophores, their solubility and absorption spectra can be significantly modified by 
altering the backbone termini. Furthermore, many contain an accessible backbone chlorine that can be 
used for introduction of a charge-transfer partner. Of the heptamethine dyes, the thiopyrilium dye IR-
1061 was chosen for initial experiments due to its NIR absorption spectrum and precedence of 
modification at its backbone chlorine.22 To rationally select an appropriate charge-transfer partner for IR-
1061, we turned to computation.   
 In a previous report, the 9-mesityl-10-methylacridinium charge-transfer dyad was evaluated using 
density functional theory (DFT), and the ground state frontier orbitals were shown to be disjoint – with 
one localized to the acridinium and the other to the orthogonal mesityl.20 To determine if this ground 
state calculation could have predictive power, we ran an analogous set of calculations on the previously 
mentioned BOD-CAT and its non-methylated derivative BOD-PY (Figure 2A) using the B3LYP 
functional and 6-31G** basis set. In BOD-PY, which does not exhibit a charge-transfer state, both the 
HOMO and the LUMO resided on the BODIPY core. However, in BOD-CAT, which does exhibit a 
charge-transfer state, the LUMO had shifted to the orthogonal N-methylpyridinium charge-transfer 
partner. This result, along with the 9-mesityl-10-methylacridinium calculations, suggested that disjoint 
Figure 1: Charge-transfer state formation. A.) 
BODIPY derivatives used to elucidate intramolecular 
charge-transfer mechanism responsible for enhanced 
triplet state formation.15 B.) Jablonski diagram 
proposed for orthogonal charge-transfer dyads.16 
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ground state frontier molecular orbitals were a characteristic of long-lived charge-transfer dyads, and thus 
the nature of frontier molecular orbitals could be used to quickly screen potential charge-transfer partners. 
We recognize that more sophisticated calculations would be required to develop a truly predictive screen, 
but we felt that this simpler set of calculations would be able to guide our experimental efforts.  
We began by evaluating a set of IR-1061 derivatives analogous to the BODIPY derivatives: IR-1061-
PY and IR-10161-CAT (Figure 2B).  In IR-1061-PY, both the HOMO and the LUMO remained on the 
heptamethine backbone, suggesting that no charge-transfer would occur. In IR-1061-CAT, the LUMO 
shifted to the N-methylpyridinium, generating a disjoint 
set of frontier molecular orbitals and suggesting that 
charge-transfer was possible. These results mirrored 
those for the BODIPY system and suggested that 
pyridinium might be a good starting point for an IR-
1061 charge-transfer dye. To complement these results, 
an N-C linked dyad, which we will refer to as IR-1061-
pyridinium, was also evaluated. The frontier orbitals 
remained disjoint, however, the LUMO and the 
LUMO+1 were significantly closer in energy (Figure 3). 
Figure 2: Charge-transfer state computational predictions. For all molecules the HOMO resides on the 
primary chromophore and the LUMO is shown. A.) Comparison of BOD-PY and BOD-CAT demonstrating a 
LUMO shift upon methylation. B.) A comparison of IR-1061-PY and IR-1061-CAT showing a similar orbital 
shift. 
Figure 3: IR-1061-pyridinium orbital energies. 
Upon inverting the pyridine charge-transfer 
partner so that it is linked via an N-C bond instead 
of a C-C bond, similar orbitals are observed. 
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Since the N-C linkage in IR-1061-pyridinium provided an opportunity for functionalization at the 
pyridine 4-position, a number of derivatives were explored. Electron withdrawing groups tended to 
reinforce the observed disjoint character, whereas 
electron donating groups did the opposite, at times 
undoing the effect all together (Figure 4). Beyond 
pyridine derivatives, a range of results were observed 
with different charge-transfer partners, with acridinium 
standing out as a potential alternative to pyridinium 
(Figure 5).  
5.3.2 Synthesis and Characterization of IR-1061-pyridinium 
 From the range of charge-transfer partners 
computationally vetted, IR-1061-pyridnium was selected 
for initial photochemical studies due to its synthetic 
IR-1061-p-nitropyridinium IR-1061-p-dimethylaminopyridinium 
Figure 4: Representative IR-1061-pyridinium derivatives. Electron withdrawing groups (p-
nitropyridinium) reinforce frontier orbital orthogonality while electron donating groups (p-
dimethylaminopyridinium) do the opposite. 
Figure 5: IR-1061-acridinium orbital 
energies. In IR-1061-acridinium the orthogonal 
orbital is heavily favored as the LUMO, 
suggesting the possibility of charge-transfer. 
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accessibility (Figure 6). IR-
1061-CAT was also 
considered, but its 
synthesis proved to be 
more challenging. The pyridine addition reaction was extremely sensitive to water, but gave good 
conversion using dry pyridine. Unfortunately, the product was too sensitive to isolate in pure form due 
to hydration that occurred under all evaluated purification conditions (Figure 7). Despite this 
inconvenience, the slightly impure dye was used as a proof of principle. For initial singlet oxygen 
generation experiments, the dye was 
dissolved in CDCl3 – the solvent in 
which it had the highest solubility – 
and irradiated using a 1 watt/cm2 980 
nm laser in the presence of a singlet 
oxygen trap, diphenylisobenzofuran 
(DPBF). DPBF was selected as a trap 
because it is a standard in the field and 
because other popular detectors (such as singlet oxygen sensor green, SOSG) led to precipitation of IR-
1061-pyridinium over time. After 30 minutes of irradiation, a significant decrease in the DPBF signal was 
observed relative to a dark control, suggesting that singlet oxygen sensitization was occurring (Figure 8A). 
Figure 6: IR-1061-pyridinium synthesis. 
Figure 7: MALDI of slightly impure IR-1061-pyridinium. 
When isolated, the major impurity at 460 amu has no absorbance 
in the NIR. 
A B 
Figure 8: IR-1061-pyridinium singlet oxygen generation. A.) Irradiation of IR-1061-
pyridinium with DPBF. The structure of DPBF is shown next to its absorbance peak. B.) 
Irradiation of IR-1061 with DPBF. 
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In comparison, the parent dye, IR-1061, was irradiated under the same conditions and no significant 
changes in DPBF signal were observed (Figure 8B).  This suggested that the designed dye had novel 
reactivity at previously inaccessible wavelengths, but a more stable derivative was required to better 
characterize the reaction. 
5.3.3 Synthesis and Characterization of IR-1061-acridinium 
In an attempt to overcome 
the susceptibility of IR-1061-
pyridinium to hydration, the 
pyridine charge-transfer 
partner was exchanged for acridine, which we suspected would shield the dye from water addition due 
to its additional bulk. Although high temperatures – and thus a solvent with a high boiling point – were 
required to synthesize the derivative (Figure 9), the product was more amenable to purification, ultimately 
yielding pure dye. The absorption spectra of IR-1061-acridinium in chloroform was taken, and notably 
had significant tailing in the NIR. This is reminiscent of spectra observed for other heptamethine dyes 
such as ICG, which demonstrate spectral shifting due to aggregation.23 To determine whether or not this 
phenomenon was specific to chloroform, the absorption spectrum was taken in a range of solvents, 
(Figure 10).  In most, the dye had a similar spectrum, however, significant peak broadening was observed 
in water.  
Figure 9: IR-1061-acridinium synthesis. 
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Figure 10: NIR absorbance of IR-1061-acridinium in multiple solvents. Spectra shown at a 
concentration of .025 mg/ml (27 µM). λmax occurs at 1078 for chloroform, with a significant tail 
suggesting possible aggregation.23 
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Like IR-1061-pyridinium, IR-1061-acridinium was irradiated in CDCl3 in the presence of DPBF using 
a 1 watt/cm2 980 nm laser (Figure 11A). As a comparison, a similar irradiation was carried out using a 
1.8 watt/cm2 1064 nm laser (Figure 11B). Under both irradiation conditions, a decrease in DPBF signal 
was observed, however, the time scales varied drastically. At 980 nm significant DPBF photobleaching 
was observed only after 30 minutes, but in just 5 minutes of irradiation at 1064 nm, near complete 
photobleaching of DPBF was observed, as well as significant bleaching of the dye. This destruction of 
the dye is to be expected in the presence of high concentrations of singlet oxygen, as heptamethine dyes 
have been used as photoremovable protecting groups on the basis of this phenomenon.6 In an attempt 
to better define the efficiency of singlet oxygen generation, we obtained a relative quantum yield by 
comparing DPBF bleaching in the presence of IR-1061-acridinium and in the presence of phenalenone, 
a compound with a high quantum yield for singlet oxygen generation on irradiation at 365 nm in 
chloroform24 (Figure 12).  The results gave a relative quantum yield of 0.3%, which must be considered 
approximate given the substantially different wavelengths involved. Although this value is low, it provides 
a starting point for 1064 nm photochemistry and a benchmark for future generations of dyes.  
Further characterization of the dye was pursued at 980 nm, where irradiation resulted in a more 
controlled reaction. To confirm that the process was singlet oxygen-mediated, irradiation of a freeze-
Figure 11: Irradiation of IR-1061-acridinium in CDCl3. A.) Irradiation of IR-1061-acridinium with a 1 watt, 
980 nm laser. B.) Irradiation of IR-1061-acridinium with a 3 watt, 1064 nm laser.  
30 Minute (1 Watt) Irradiation at 980 nm 5 Minute (3 Watt) Irradiation at 1064 nm 
5 
A B 
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pump-thawed sample – devoid of oxygen – 
was carried out. This irradiation produced no 
change in DPBF signal (Figure 13), suggesting 
that the process is indeed singlet oxygen 
mediated. 
 To evaluate the scope of the reaction, the 
dye was irradiated in an array of (deuterated) 
solvents. In nonpolar solvents, such as toluene, 
no singlet oxygen generation was observed. In 
polar aprotic solvents, such as DMSO, 
irradiation of the dye led to decreased DPBF 
degradation as well as photobleaching. In 
water, DPBF degradation rates comparable to those seen in chloroform were accompanied by high levels 
of photobleaching (Figure 14). Strong acids and bases both led to dye instability and bleaching prior to 
irradiation, and introduction of protein (in the form of BSA) led to precipitation of the dye. Exchanging 
the counterion from BF4- to BArF- resulted in an increase in solubility, but also a marked decrease in 
photosensitization capability. These results suggest that both the dye and the photosensitization process 
are sensitive, requiring further optimization to produce a practical photosensitizer. 
Figure 12: Quantum yield determination. Normalized 
decrease in DPBF signal following irradiation in the 
presence of phenalenone or IR-1061-acridinium. An 
approximately 200-fold greater photon flux was used to 
irradiate IR-1061-acridinium. 
Figure 13: Irradiation of IR-1061-acridinium and 
DPBF in freeze-pump-thawed CDCl3. 
Figure 14: Irradiation of IR-1061-acridinium in 
D2O. 7.5% DMSO-D6 used for solubilization.  
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5.4 Conclusion  
 Generation of a dye capable of any photochemistry past 900nm is a significant achievement and marks 
a first in the field. These early studies provide a proof of concept for a new class of photoreactive 
compounds. Clearly, more optimization will be required to create a practically useful material. In addition, 
detailed mechanistic studies will be needed to confirm the proposed charge-transfer mechanism.  The 
reactivity of both IR-1061-pyridinium and IR-1061-acridinium support the design principles used to 
conceptualize the dyes as well as the predictive value of the performed calculations. These dyes provide 
insight into a challenging problem and serve as an important step as the field works towards novel NIR 
photochemical reactivity. 
5.5 Materials and Methods 
5.5.1 Materials 
IR-1061 tetrafluoroborate and dry pyridine were purchased from Sigma Aldrich. Acridine was 
purchased from Alfa Aesar. Sodium BArF was purchased from AK Scientific. Deuterated solvents were 
purchased from Cambridge Isotopes and used as received, with the exception of deuterated chloroform, 
which was filtered through a neutral alumina plug prior to use to neutralize and dry the solvent. 
Commercial reagents and solvents were purchased from Sigma-Aldrich, VWR, and Thermo-Fisher 
Scientific and used as received. Reactions involving air or moisture sensitive reagents were run under 
argon, with samples purged of air prior to use. Flash chromatography was performed using neutral silica 
gel from Merck (230-400 mesh). TLC analysis was performed with plates from Merck (60 A pore size, 
F254, 0.25 mm). 
5.5.2 Instrumentation  
Irradiations at 980 nm were performed using a 1 watt/cm2 infrared diode laser at 980 nm coupled to 
a PSU-III-FDA power supply. Both the laser and the power supply were purchased from CNI lasers. 
Irradiations at 1064 nm were performed using an Nd:YAG laser at 1.8 W/cm2. Absorbance spectra were 
obtained using an Agilent CARY 60 UV-Vis for spectra below 1000nm, and a Cary 5000 UV-VIS-NIR 
for spectra above 1000 nm. Mass spectrometry characterization was performed via MALDI using a 
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BRUKER MALDI/TOF Autoflex Speed and a Waters LCT Premier XE Electrospray TOF. 1H NMR 
spectra were obtained using a Varian 600 MHz Spectrometer. Chemical shifts are reported in parts per 
million (ppm, δ) referenced to the residual 1H resonance of the solvent. Splitting patterns are designated 
as follows: s, singlet; br, boad; d, doublet; dd, doublet of doublets; t, triplet; q, quarted; m, multiplet.  
5.5.3 Calculations 
Computation was performed using the SPARTAN interface with calculations performed using the 
B3LYP functional and the 6-31G** basis set. These calculations were performed in accordance with 
previous calculations performed on the 9-mesityl-10-methylacrindium dyad.20 Higher levels of 
computation (using the MO6 functional and larger basis sets) were performed on the BODIPY dyads to 
check for differences, and none were observed. Given the large size of the IR-1061 dye and the lack of 
significant differences in higher level calculations, we felt that B3LYP and 6-31G** were the most 
appropriate selection.   
5.5.4 Irradiation Experiments 
 Dye was dissolved in deuterated solvent at a concentration that would produce an absorbance near 1 
at 980 nm. This was calculated using extinction coefficients determined by absorbance measurements of 
the dye alone. The IR-1061-acridinium irradiation in water was an exception, as the concentration was 
kept lower to ensure solubility. Dye solution was split into two aliquots and added to two 1 cm by 1 cm 
quartz cuvettes purchased from Starna. The absorption spectra were taken for both cuvettes (to ensure 
the pre-irradiation sample looked the same in both cases), and subsequently one cuvette was irradiated 
while the other was kept in the dark. A stir bar was used to ensure proper mixing during irradiation. After 
irradiation, the absorbance of both solutions was again evaluated. Figures shown without a dark control 
still had one, however, no significant change was observed in the irradiated sample so the dark control 
trace was unnecessary and therefore not included. For the 1064 nm irradiation, the dye was dissolved at 
a slightly higher concentration to an absorbance of approximately 1.5 at 1064 nm and irradiated for 5 
minutes. At this point significant photobleaching of the dye was observed, so additional irradiation was 
not performed. 
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 The freeze-pump-thaw (FPT) experiment was carried out as follows. Dye was dissolved in deuterated 
chloroform and added to a FPT apparatus. Three consecutive freeze-pump-thaw cycles were carried out 
to a pressure of less than 200 mm Hg, at which point the solution was transferred under vacuum to the 
arm of the apparatus containing a fused 1 cm by 1 cm quartz cuvette (Starna). Irradiation and subsequent 
absorption measurements were carried out in the sealed cuvette.  
5.5.5 Relative Quantum Yield Calculation 
 Phenalenone (Sigma-Aldrich), a highly efficient singlet oxygen generator with a known singlet oxygen 
quantum yield of 0.97 in chloroform24 was used to benchmark the efficiency of IR-1061-acridinium 
singlet oxygen generation in chloroform. A solution of phenalenone at an absorbance of 0.30 at 365 nm 
was generated that also contained DPBF at an absorbance of approximately 1.0. This solution was 
irradiated for 30 seconds using a 365 nm variable power LED (3-300 mW, Thor labs) at 30 mW/cm2. 
The percent decrease in DPBF signal at 415 nm was calculated, taking into account any background from 
phenalenone. This was done in triplicate. A similar experiment was then run using IR-1061-acridinium. 
A solution containing the dye at an absorbance of 0.30 at 1064 and DPBF at an absorbance of 
approximately 1.0 was irradiated for 30 seconds using a 1064 nm Nd:YAG laser with a power output of 
1.8 W/cm2. The percent decrease in DPBF signal at 415 nm was then calculated, taking into account any 
background from IR-1061-acridinium. This was also done in triplicate. 
 The percent decrease attributed to phenalenone was calculated to be 53% and the percent decrease 
attributed to IR-1061-acridinium was calculated to be 29% (Figure S8). To take into account the 
difference in photon flux at these two wavelengths, the ratio of the photon flux was calculated, where the 
photon flux was described by the following equation: PF = I*λ/(h*c*Na). PF stands for photon flux, I is 
the irradiation intensity, λ is the irradiation wavelength, h is Planck’s constant, c is the speed of light and 
Na is Avogadro’s number. The ratio of the photon flux was simplified to PFR = (IPhe*λPhe)/(IIR* λIr) = 
(0.03 W/cm2*365 nm)/(1.8 W/cm2*1064 nm) = 0.006. Taking into account this difference in photon 
flux and phenalenone’s known quantum yield of singlet oxygen generation of 0.97, this yields a relative 
quantum yield of about 0.003, or 0.3%. 
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5.5.6 Syntheses 
 
IR-1061-pyridinium  
 A 10 mL flame-dried round-bottom flask was charged with a stir bar and 25 mgs of IR-1061, to which 
1 milliliter of dry pyridine was added. The reaction was heated to boiling under argon, and removed from 
heat once the solution transitioned from dark red to greenish-brown. At this point the compound was 
purified by silica gel chromatography using a 0-5% MeOH in DCM gradient. The product could not be 
cleanly purified due to decomposition during purification. All other attempted purification conditions 
gave the same result. Due to low solubility and contaminating species, an interpretable NMR was never 
obtained. However, a reasonably clean mass spectrometry trace was. Interestingly, the M-1 mass was 
observed, presumably due to loss of a proton to alleviate the dual positive charge. MALDI-MS (m-1) 
calculated: 704.24, found 704.06. 
 
IR-1061-acridinium 
 A 10 ml round-bottom flask was charged with a stir bar, 25 mgs of IR-1061 (1 equivalent), and 60 
mgs of acridine (10 equivalents). Two milliliters of anisole were added, and the reaction was heated to 
boiling under argon. It was removed from heat once the color changed from red to a yellow hued brown. 
Further heating led to formation of a green decomposition product. The reaction mixture was loaded 
onto a silica plug, and after eluting the anisole and any nonpolar compounds with DCM, a polar fraction 
containing the dye of interest was eluted with 5% MeOH in DCM. After pumping down, this polar 
fraction was resuspended in DCM and loaded onto a silica gel column, which was eluted with a 0-2% 
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MeOH in DCM gradient. 20 mgs of pure product were collected as a brown-yellow compound, giving a 
percent yield of 64%. 1H-NMR (600 MHz, CDCl3): 7.75 (m, 2H), 7.68-7.60 (m, 12H), 7.52-7.42 (m, 14 
H), 6.99 (t, 2H) 6.91 (d, 2H), 6.65 (t, 2H), 6.59 (d, 2H), 6.28 (m, 1H), 2.84 (t, 2H), 2.56 (t, 2H), 1.95 (m, 
2H). ESI-TOF-MS (m-1) calculated: 804.275, found 804.277. 
 
IR-1061-acridinium BArF 
IR-1061 BArF was synthesized and purified in the manner described by Shi et al.22 Following isolation, 
25 mgs of IR-1061 BArF (1 equivalent) was added to a 10 ml round-bottom flask along with a stir bar 
and 29.3 mgs of acridine (10 equivalents). Two milliliters of anisole were added, and the reaction was 
heated under argon. It was removed from heat once the color changed from red to a yellow hued brown. 
Further heating led to formation of a green decomposition product. The reaction mixture was taken up 
in DCM and extracted three times with water and once with brine. The DCM fraction was pumped to 
near dryness, then resuspended in DCM and loaded onto a silica gel column. The product was eluted 
with a 0-1% MeOH in DCM gradient. 12 mgs of pure product were collected as a brown-yellow 
compound, giving a percent yield of 43%. NMR and mass spec data matched that of IR-1061-acridinium 
tetrafluoroborate, although significant peak broadening was observed on the MALDI with the BArF 
counterion. 1H-NMR (600 MHz, CDCl3): 7.75 (m, 2H), 7.68-7.60 (m, 12H), 7.52-7.42 (m, 14 H), 6.99 (t, 
2H) 6.91 (d, 2H), 6.65 (t, 2H), 6.59 (d, 2H), 6.28 (m, 1H), 2.84 (t, 2H), 2.56 (t, 2H), 1.95 (m, 2H). MALDI-
MS (m-1) calculated: 804.3, found 804.5. 
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